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During the fall of2014, in what seemed like a change of heart, Republican congressional
candidates began calling for a policy that reproductive rights advocates have supported
foryears. Over-the-counter ("OTC') oral contraception ("OC') became these candidates'
way to connect with the women alienated by the Republican Party in recent elections.
They emphasized how OTC access would allow women themselves, not employers or
the government, to have control over contraceptive decisions. Liberals responded that
this new effort was just a Trojan horse legalizing OTC access would not only increase
the actual price tag on OC, but it would also remove OC from the Patient Protection
and Affordable Care Act ' extended insurance coverage of contraception. Additionally,
reproductive rights advocates noted that it is the Food and Drug Administration ("FDA'),
not Congress, that legalizes OTC drugs, and the FDA has not received any applications
from drug manufacturers who want to sell OC OTC.
In reality, both sides have something ofa validargument. OTC OC wouldbe an important
step toward reproductive autonomy for American women. It is also correct, however, that
an immediate liberalization of OTC presents several issues, economically, politically, and
culturally. Despite these valid critiques, OTC access for OC is a change that is worth the
time and effort to move pastpolitics and get it right, for many reasons. Requiring insurance
companies and Medicaid to reimburse women for OTC OC purchases is a step toward
establishing an accessible market and ensuring corresponding reproductive autonomy for
women in the United States, which should accompany legalization of OTC OC.
* I would like to thank Professor Carol Sanger, for all of her helpful advice and critiques. I would also
like to thank Professor Scott Hemphill for consulting on economic theory, and Sharon Hickey for her feedback
and comments. Thanks also to Emma Kaplan, Esi Agbemenu, Kate Gadsden, and Jacqueline Ma for their
outstanding and essential editing.
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INTRODUCTION
In 2014, Americans spent a lot of time, energy, and money arguing about oral
contraception ("OC" or "birth control pills")-specifically, who should pay for it. Yet,
the public debate surrounding whether employer-sponsored insurance plans should cover
OC was mostly unproductive as far as advancing women's reproductive autonomy is
concerned. That is because the current United States prescription-only access system for
birth control pills fails to serve the needs of the women who stand to gain the most from
access to OC. The employer mandate debate only took us further away from realizing a
system that would promote access for all women-that is, legalizing an over-the-counter
("OTC") Food and Drug Administration ("FDA") designation for OC instead of limiting it
to prescription-only status.
Despite the seemingly groundbreaking contraceptive mandate in the Patient Protection
and Affordable Care Act of 2010 ("ACA"), which transferred responsibility for the
monetary cost of OC from women to their insurance companies,1 all women's access
to OC did not improve, nor was the controversy surrounding it reduced. The ACA's
provision that insurers have to now pay for OC was intensely contentious among the
American public, and the Supreme Court ruled in 2014 that employers with a religious
objection to contraception do not have to comply with the ACA's employer mandate.2 This
controversy took attention away from the fact that, notwithstanding the obvious benefits
of reducing the price of reproductive planning for women with employer insurance plans,
the contraceptive mandate fails to help large segments of women, some of whom stand to
benefit most from increased access to OC-specifically women who are unemployed, work
part time, are undocumented, or are still on their parents' health insurance3-and fails to
address the problematic nonmonetary costs of the prescription access system. OTC access
would address these issues. With the approval of the American College of Obstetricians
1 42 U.S.C. § 300gg-13(a)(4) (2012).
2 Burwell v. Hobby Lobby Stores, Inc., 134 S. Ct. 2751, 2751 (2014).
3 See, e.g., ADAM SONFIELD ET AL., GUTTMACHER INST., THE SOCIAL AND ECONOMIC BENEFITS OF WOMEN'S
ABILITY TO DETERMINE WHETHER AND WHEN TO HAVE CHILDREN (2013), http://www.guttmacherinstitute.com/
pubs/social-economic-benefits.pdf [http://penna.cc/HXY2-PVFZ] ; Nicole M. Hartz, Note, Adequate
Assurance or Medical Mediocrity: An Analysis of the Limits on the Affordable Care Act Application to
Women s Health, 20 Wm. & MARY J. WOMEN & L. 245, 257 (2013); Phyra M. McCandless, Note, The Fallacy of
Mandating Contraceptive Equity: Why Laws That Protect Women with Health Insurance Deepen Institutional
Discrimination, 42 U.S.F. L. REv. 1115, 1116-17 (2008).
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and Gynecologists,4 OTC access is a safe proposal from a public health perspective and
one that women want.'
This Note argues that legalizing OTC access is safe, desirable, and furthers women's
autonomy over reproductive decisions. It also cautions that certain economic, political,
and cultural issues might impede immediate implementation. In Part I, I analyze which
categories of women benefit from access to OC and how they benefit. I look at the
empirically demonstrated advantages of OC and reasons women give for seeking to
use OC. I also examine the effect of cost (both the monetary and the nonmonetary costs
associated with prescription access) on OC usage. Part II addresses the ways in which the
ACA falls short of fully ensuring access to oral contraceptives and protecting reproductive
autonomy. It analyzes how the ACA's contraceptive benefits do not extend fully to multiply-
marginalized 6 women and how continued reliance on employer-sponsored health plans
impairs overall ability to obtain OC. Part III details how OTC access would address these
deficiencies and promote access. These reasons include women's own preference for OTC
access, the medical safety of OTC access, the successful examples of OTC emergency
contraception in the United States and OTC OC in other countries, and OTC's protection
of autonomous reproductive decisions. Part IV examines the economic, political, and
cultural reasons why immediate implementation could be problematic, even though OTC
4 AM. COLLEGE OF OBSTETRICIANS & GYNECOLOGISTS, COMMITTEE OPINIONNO. 544: OVER-THE-COUNTERACCESS
TO ORAL CONTRACEPTION (2012), http://www.acog.org/Resources-And-Publications/Committee-Opinions/
Committee-on-Gynecologic-Practice/Over-the-Counter-Access-to-Oral-Contraceptives [http://perma.cc/
QVY6-EX88] [hereinafter COMMITTEE OPINION No. 544: OTC ACCESS].
5 See, e.g., Sharon Cohen Landau, Birth Control Within Reach: A National Survey on Women Attitudes
Toward and Interest in Pharmacy Access to Hormonal Contraception, 74 CONTRACEPTION 463 (2006); Kate
Grindlay et al.,Attitudes Toward Over-the-Counter Access to Oral Contraceptives Among a Sample ofAbortion
Clients in the United States, 46 PERSP. ON SEXUAL & REPRODUCTIVE HEALTH 83 (2014) [hereinafter Grindlay et
al., Attitudes Toward OTC Access].
6 Multiply-marginalized individuals are those who identify with more than one group or characteristic
against which society discriminates. See CATHERINE E. HARNOIS, FEMINIST MEASURES IN SURVEY RESEARCH 128
(2013):
Systems of race, gender, class, and sexuality intersect at the individual level, the
institutional level, and every level in between. It is not simply that multiply marginalized
individuals expeience multiple forms of discrimination (e.g., racial discrimination, gender
discrimination, and class-based discrimination). Nor is it simply that multiply marginalized
individuals experience discrimination based on multiply marginalized statuses (e.g.,
racialized gender-discrimination and gendered class-discrimination). Rather, socially-
constructed notions of race, class, gender, sexuality, age, physical ability, and ethnicity are
all built into and maintained by our political, economic, and cultural institutions[.]
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is a good idea overall. In particular, a dual OTC and prescription system could skew an
OTC market for OC, if insurers fear losing their market power with drug companies and
continue requiring prescriptions for OC coverage. I then propose ways the United States
could overcome these obstacles. Specifically, I suggest that the FDA should approve any
citizen petition it receives requesting OTC status for OC, and, concurrently, the Department
of Health and Human Services ("HHS") should update their regulations to require insurers
and Medicaid to reimburse women for OTC OC purchases. This change would, in effect,
create an incentive for insurance companies and the federal government to have a stake in
the competitiveness of the OTC OC market.
I. Who Benefits From Access to Oral Contraception and How So?
OC was approved for sale in the United States on May 11, 1960.7 Since then, millions
of American women have relied on it to prevent pregnancy, among other uses like
controlling menstruation or acne treatment. While OC generally provides more control
over reproductive decisions for women, that ability itself produces spillover benefits too
that affect individual women in varying ways. Women cite a wide range of reasons for
utilizing contraception, and they derive many distinct benefits from it.8 This is partially
due to the intersection of factors that affect women's access to, usage of, and benefits
derived from OC. Cost, in particular, does not affect women's usage of OC uniformly.9
Understanding these differences is important for analyzing how a particular access system
either promotes or impairs women's usage.
A. What are the Benefits of Oral Contraception?
When first introduced in 1960, OC was the first contraceptive to afford women
themselves full control over reproductive decisions. OC's main benefits flow from the
basic improvement of allowing women to better plan whether and when they want to be
7 That is, sale for contraceptive usage. The first OC, the Enovid pill, had been previously approved for
sale for the purpose of regulating periods. When this happened in 1959, a huge increase in women reporting
irregular periods to their doctors occurred. Timeline: the Pill, PBS Am. EXPERIENCE, http://www.pbs.org/wgbh/
amex/pill/timeline/timeline2.html [http://penna.cc/32YS-4EKU] (last visited Jan. 27, 2015). Even after OC
was legalized for contraceptive use, it was not legal for unmarried women to use it for that reason until 1972.
Eisenstadt v. Baird, 405 U.S. 438, 438 (1972).
8 Jennifer J. Frost & Laura Duberstein Lindberg, Reasons for Using Contraception: Perspectives of US
Women Seeking Care at Specialized Family Planning Clinics, 87 CONTRACEPTION 465, 465 (2013).
9 Emily Gray Collins & Brad Hershbein, The Impact of Subsidized Birth Control for College Women:
Evidence from the Deficit Reduction Act (2013) (unpublished manuscript) (on file with authors).
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pregnant. 10 The choice over this fundamental reproductive decision allowed, and continues
to allow, women to have more control over their careers, as well as their personal lives.
Economic studies have explored what kinds of benefits are associated with women's
increased ability to plan their pregnancies. The liberalization of OC in the late 1960s and
early 1970s helped isolate the link between increasing access to OC and multiple important
economic indicators of an individual's well-being. Martha Bailey, a labor economist at the
University of Michigan, has conducted a series of studies" using states' legalization of access
to OC for eighteen- to twenty-one-year-olds as an exogenous policy change to separate the
empirical consequences of increased oral contraceptive access from other developments
during this time period.12 Her studies have found that women's access to OC increased
their labor force participation, wages, and family incomes, as well as their children's ability
to complete college decades later.13 She also linked increased determination of when to
have children with positive impacts on quality-of-life indicators, including educational
attainment, economic stability, lasting union formation, and mental health and happiness.14
More broadly, the ability to plan whether and when to be pregnant leads to its own
positive spillover effects. This control has increased both the proportion and the number of
10 Martha J. Bailey et al., Recent Evidence on the Broad Benefits ofReproductive Health Policy, 32 J. POL'Y
ANALYSIS & MGMT. 888, 889 (Autumn 2013).
11 Despite the effective methodology employed in these studies, it is hard to duplicate or expand their use.
Bailey's studies make use of a policy change that occurred in a distinct time period, which usefully varied
slightly across states. Now that access to OC has expanded enormously, it would be hard, if not impossible, to
isolate such a change in a similar contemporary study. This makes any such contemporary research perhaps
less able to isolate the impact of a particular policy. The more relevant consideration today, instead of OC's
availability, would be the consistency and adequacy of use. Before any such study could be done, though, more
time would need to pass so that relevant data would be available, making it less relevant for contemporary
policy decisions. For modem policy concerns, what is important to glean from these studies is that access to
OC, when it was new and its impact most easily visible, markedly improved several quality-of-life indicators
for United States women. This should inform present efforts to increase access for all segments of the female
United States population. See SONFIELD FT AL., Supra note 3, at 27; Martha J. Bailey, More Power to the Pill: The
Impact of Contraceptive Freedom on Women Life Cycle Labor Supply, 121 Q. J. ECON. 289, 317-18 (2006).
12 SONFIELD ET AL., supra note 3, at 27.
13 SONFIELD ET AL., supra note 3, at 27; Martha J. Bailey, Fifty Years of Family Planning: New Evidence on
the Long-Run Effects of-Increasing Access to Contraception (Nat'l Bureau of Econ. Research, Working Paper
No. 19493, 2013) [hereinafter Bailey, Fifty Years] (determining how precisely access to OC impacts indicators
like education level or lifetime labor supply, by isolating an exogenous change in availability, to compare the
before and after statistics and how the changes correlate).
14 Bailey, Fifty Years, supra note 13, at 1.
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women in professional degree programs.1 5 Women with high educational achievement are
then able to benefit financially by delaying childbirth, as they can complete more schooling
and concentrate on advancing their careers. 16 The increased ability to plan when to have
children also leads to stronger relationships, 17 less anxiety and depression, and higher
happiness levels for parents.18 The use of birth control pills can also allow women to form
more stable partnerships; OC reduces the effect of unexpected pregnancies on women's
decision to marry, meaning that the partnerships formed by women utilizing OC can be
made later on in life and so can be more considered. 19
1. Who Benefits Most from Oral Contraception?
As for who benefits most from oral contraception, studies that have been done to
date have not adequately broken down the data. Nearly all of the studies in this area have
focused on either the averages of large samples or specific subgroups for methodological
reasons, which is not helpful in assessing OC's long-term impact for certain demographic
groups.20 While there has been considerable work completed examining the correlation
between increased control over the timing of one's pregnancy and other quality-of-life
factors, there has been little study of how this increased control affects women who are
marginalized or multiply-marginalized. 21 These studies have missed women on certain
relevant margins, and so it is possible that available studies have neglected the most salient
impact of increased access to OC. The few studies that have considered these women
indicate that
contraceptive access or unintended pregnancy may influence different
women in different ways, according to their income, race and ethnicity,
marital status and other characteristics. Young women who start out
disadvantaged-for example, without many individual or familial
economic resources-may benefit most from completing their education
15 Bailey, Fifty Years, supra note 13, at 9.
16 See supra note 13, at 17.
17 SONFIELD ET AL., supra note 3, at 19.
18 SONFIELD ET AL., supra note 3, at 22.
19 SONFIELD ET AL., supra note 3, at 19.
20 SONFIELD ET AL., supra note 3, at 27.
21 SONFIELD ET AL., supra note 3, at 27.
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and may be least able to achieve income and relationship stability when
facing the demands of teen motherhood. Single mothers, who do not have
the benefit of sharing expenses and the time and emotional demands of
parenthood with a partner, may have less ability than do other mothers
to invest in their own education and to pursue high-income careers with
employers supportive of working mothers.22
This distinction is relevant in that it is precisely those who would likely stand to benefit
most from an increased ability to plan pregnancies are left out of many studies, and are
largely excluded from insurance coverage under the ACA, as well.23
Further, women on the margins may also simply benefit less than non-marginalized
women from the ability to plan their pregnancies further in advance and with more certainty,
under the current prescription-only system:
Unfortunately, judging from the limited number of studies that explore
differences across groups of women, it does not appear that all United
States women have benefited equally from access to contraception.
Being able to plan whether and when to have children, for example, has
not benefited low-income women and women of color in terms of their
education as greatly as it has benefitted their higher-income and white
counterparts. Similarly, because lower-income and single mothers with
lower levels of education may have less freedom in their choices of when
and where to work than do other women, theirjob security does not benefit
as much from contraceptive access.24
This is not to say that low-income women, women of color, and single mothers do
not benefit from access to OC-they simply do not benefit in the same ways as white
women, women with higher incomes, or women with other relevant characteristics. 25 With
a diversity of available benefits comes a diversity of reasons for seeking OC. However,
22 SONFIELD ET AL., supra note 3, at 27. The disconnect between data-driven social science methods and
women's studies analyses of intersectionalities in general has been noted by Leslie McCall. Leslie McCall, The
Complexity ofIntersectionality, 30 J. WOMEN IN CULTURE & Soc'y 1771, 1794-96 (2005).
23 See infra text accompanying notes 70-75.
24 SONFIELD ET AL., supra note 3, at 29.
25 SONFELD ET AL., supra note 3, at 29.
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the current insurance-based health care system fails to provide the flexibility needed to
accommodate women's varying needs.26
2. Reasons for Using (or Not Using) Oral Contraception
It is a simplification to assume that all American women are looking for or expecting
the same benefits when they get a prescription for OC. To fully understand women's
demand for OC, looking to women's own individual accounts is instructive. Their reasons
differ across characteristics like age, education, race, and income. Unemployment is a
particularly strong driver of demand for OC across many different segments of the female
population.27 Although female study participants do not always cite cost as an important
factor in their use of OC, empirical evidence indicates that increased costs, both monetary
and nonmonetary, decrease women's demand for OC. Examining these distinctions sheds
light on the incentives women consider when they decide to use OC. To explore what
explains the differences cited, economists have asked women to describe their personal
reasoning and then analyzed connections within the data.
A study of women receiving services from specialized family planning clinics
corroborates the assertion that women on the margins, as opposed to women who fit into
an aggregated norm, cited more reasons for seeking OC. 28 In this study, women reported
a range of reasons for using birth control, including: taking better care of themselves and
their families, supporting themselves financially, finishing their education, and keeping or
getting a job.29 Young women, women without children, and women who were not married
reported more reasons than other women.: ° Being young and being single were correlated
with the most reasons for seeking OC, and these indicators were followed by education,
race, and income.31
Unemployment constitutes another significant reason for seeking access to OC:
unemployment was a very important self-reported factor for over a quarter of study
26 For a discussion of how structural factors impact these varying needs, see infra notes 66-78 and
accompanying text.
27 Frost & Lindberg, supra note 8, at 467.
28 Frost & Lindberg, supra note 8, at 468.
29 Frost & Lindberg, supra note 8, at 468.
30 Frost & Lindberg, supra note 8, at 468.
31 Frost & Lindberg, supra note 8, at 468.
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participants.3 2 In the study, the particular magnitude of this statistic is attributed to
coincidence of the completion of the study and the financial crisis of 2008, but under the
ACA's access structure for OC such a consideration is telling no matter the health of the
overall economy. Currently, as the ACA funds OC under employer-sponsored insurance
plans, an unemployed woman seems to have both more demand for and interest in OC
and yet less access and funding for it. Drawing this comparison one step further, because
insurance is linked to employment under the ACA, women who are unemployed are more
likely to be uninsured as well-and, uninsured women are more likely than insured women
to use no contraceptive method at all and also less likely to use OC, due to issues of access,
not preference.33
a. Cost as a Factor For Oral Contraceptive Usage
In contrast to other factors, women only sometimes cite cost as a deterrent from seeking
OC access. In one study, a mere fourteen percent of women aged eighteen to twenty-nine
stated that cost was a factor in choosing to use less effective forms of contraception.3 4
Another study found that women visiting family planning clinics also rarely mention cost
as a reason for not using contraception.35 Young women attending community college
stated that they did not worry about low-cost access to contraception-mostly thanks to
the reproductive services resources Planned Parenthood makes available.36 This particular
statistic is slightly incongruous, though, as one in ten women in the same study cite the
difficulty of accessing contraception as their reason for non-use.
This does not necessarily mean that increased cost does not lessen demand for OC.
There are several reasons why these studies did not pick up costs' effects. For example,
32 Frost & Lindberg, supra note 8, at 467.
33 JENNIFER J. FROST ET AL., GUTTMACHER INST., In BRIEF: IMPROVING CONTRACEPTIVE USE IN THE UNITED STATES
6 (2008).
34 NAT'L CAMPAIGN TO PREVENT TEEN & UNPLANNED PREGNANCY, MAGICAL THINKING: YOUNG ADULTS'ATTITUDES
AND BELIEFS ABOUT SEX, CONTRACEPTION, AND UNPLANNED PREGNANCY 11 (2008), http://thenationalcanpaign.org/
sites/default/files/resource-primary-download/magicalthinking.pdf [http ://penna.ccNC7D-QHTN].
35 FROST ET AL., supra note 33, at 6.
36 Joanna Reed et al., Consistent and Inconsistent Contraception Among Young Women: Insights from
Qualitative Interviews, 63 FAm. REL. 244, 256 (2014).
37 Id.
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many women may find it difficult to admit in an interview38 that cost is an issue. Or,
perhaps the question and study design themselves diminish the influence of cost: contrary
to the aforementioned studies, in a 2009 study women most frequently cited "worry about
side effects, worry about weight gain, and cost" as "reasons for not obtaining desired
contraception."3 9 Framing the question to be about what factors are barriers, as opposed
to which are draws, better elicited women's cost concerns. It is also plausible that women
who cannot afford OC are simply left out of the sample size, as most studies survey women
who are already accessing family planning services.40
Changes in the amount of subsidies for contraceptive access also reveal how pricing
affects women's demand for OC. Medicaid changes and the Deficit Reduction Act ("DRA")
indicate how changes in price correlate with changes in usage, and such legislation has
specific detrimental effects cost-wise for women utilizing family planning clinic services.
As previously discussed, OC offers more potential benefits to women who are marginalized,
and women on the margins disproportionately utilize public resources like federally funded
clinics to access OC. 41 As such, how changes in subsidy amounts affect usage of OC is
particularly relevant when considering how best to implement a law changing the structure
of OC access. 42 Medicaid subsidies, for example, effectively decrease the cost of OC.
When subsidies are cut back, the cost of OC rises, and "the cost of effective contraception
puts upward pressure on the rate of unintended pregnancy. ''43
38 For discussion on the various problems associated with qualitative interviewing, see, e.g., ROBERT S.
WEISS, LEARNING FROM STRANGERS: THE ART AND METHOD OF QUALITATIVE INTERVIEW STUDIES 147-50 (1994);
Mark Goldszmidt et al., On the value of the 'subjective'in studies of human behavior and cognition, PERSP.
ON MED. EDUC. 1 (Jan. 2015), http://link.springer.com/article/I0.1007/s40037-015-0154-3 [http://penna.cc/
UQQ8-239U]; Kathryn Roulston et al., Interaction Problems in Research Interviews, 14 QUALITATIVE RES. 277
(2014).
39 Juell B. Homco et al., Reasons for Ineffective Pre-Pregnancy Contraception Use in Patients Seeking
Abortion Services, 80 CONTRACEPTION 569, 571 (2009).
40 See SONFIELD ET AL., supra note 3, at 21-22.
41 See FROST ET AL., supra note 33.
42 See FROST ET AL., supra note 33.
43 Adam Thomas, Note, Unintended Pregnancy and Public Policy, 26 NOTRE DAME J.L. ETHICS & PUB.
POL'Y 501, 512 (2012).
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Economists have specifically calculated the change in use that an increase in price of
OC will cause using a sample of college women.44 The DRA cut college health centers'
subsidy for birth control pills, which raised the cost of OC at these centers by fifty percent.
This cut substantially lowered college women's demand for birth control pills45-the result
of the DRA reduced usage of birth control pills by three to four percent among college
women.46 As a secondary effect of lessened access to birth control pills, college women
who stopped taking OC due to rising prices will either engage in riskier sexual activity or
decrease their sexual activity.47 Neither is optimal for achieving both public health goals
and reproductive freedom.
Some commentators have gone further than just observing the effects of such policy
changes and have applied an equal protection argument to the DRA's impact. There is
an argument that the DRA of 2005 constitutes a violation of equal protection because it
deprives women of benefits that they are entitled to under Title X and Medicaid by making
contraception "exorbitantly expensive" and therefore unavailable. 48 The DRA specifically
declined to include community and campus health centers as organizations that could
receive an exemption for subsidizing their prescriptions, making OC more expensive for
the women seeking care at either type of clinic. 49 Again, considering how women seeking
the services at these clinics are likely to stand to benefit in more ways from increased
access to OC, these changes impede some of the most important benefits birth control pills
have to offer.
Cost is also a complicated issue because, apart from monetary cost, additional barriers
to access-or nonmonetary costs-increase a woman's perceived cost of taking OC as
well. ° Currently, to get a prescription for OC, a woman needs to schedule an appointment
44 Collins & Hershbein, supra note 9.
45 Collins & Hershbein, supra note 9.
46 Collins & Hershbein, supra note 9 (calculating that women's elasticity of demand, then, for birth control
pills is between -.09 and -.04).
47 Collins & Hershbein, supra note 9.
48 Rachel V. Rose, Cutting Funds for Oral Contraceptives: Violation of Equal Protection Rights and the
Disparate Impact on Women Health Care, 5 MOD. Am. 23, 27 (2009).
49 Id.
50 Amanda Dennis & Daniel Grossman, Barriers to Contraception and Interest in Over-the-CounterAccess
Among Low-Income Women: A Qualitative Study, 44 PERSP. ON SEXUAL & REPROD. HEALm 84, 88 (2012).
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with a doctor, disclose a large amount of personal information (including sexual history
and activity), usually have an exam, and then make arrangements to receive the pills
themselves-likely through some kind of pharmacy-but only after checking with her
insurance to make sure it covers that particular source of medication 1 These might seem
like small nuisances, 52 but they can provide substantial barriers to obtaining OC and to
using it consistently.5 3 The overall combination of both the actual price plus the additional
nonmonetary costs constitutes the cost practically relevant to women when they are
deciding among contraceptive options.
II. Why Do the ACA's Provisions for Oral Contraception Fall Short?
The main focus of the ACA was insurance industry reform,54 not increasing OC use.
Nevertheless, the ACA did seek to shift OC's cost allocation, but this shift did not do much
to help those whose access was previously most impaired. This result is due to the way
that the employer-sponsored system interacts with other characteristics, like race, primary
language, income level and type of work arrangement, geography, and age, to create
barriers that impede access to OC more for some women than it does for others. Because
of this confluence of factors, the access structure under the ACA is still unequal. The ACA
additionally shifted public support and policy energy away from the issue of OC access, by
creating controversy around the employer-sponsored structure.
Contraception was one of several services for which the ACA sought to reduce out-of-
pocket patient costs, specifically by requiring insurance plans to cover OC with no cost to
patients.5 This shifted the monetary costs of OC from individuals to insurance companies
51 Id. at 87.
52 Some women feel that they are just that and that they do not pose a larger issue. Id.
53 Id.
54 Key Features of the Affordable Care Act by Year, HHS, http://www.hhs.gov/healthcare/facts/timeline/
timeline-text.html [http://penna.cc/8HPD-W3FH] (last visited Jan. 27, 2015).
55 Id. The ACA requires that new private health plans written on or after August 1, 2012, cover
,contraceptive counseling and services and all U.S. Food and Drug Administration-approved methods without
out-of pocket costs to patients." GUTTMACHER INST., STATE POLICIEs IN BREF I (Mar. 1, 2015), http://www.
guttmacher.org/statecenter/spibs/spib _CC.pdf [http://permna.cc/2XW9-HN9Y]. Older plans do not have to
meet that requirement, but they will be phased out of protection under the ACA over the next few years. Id.
Burwell v Hobby Lobby, Inc. may allow certain employers to opt out of this coverage. 134 S. Ct. 2751, 2751
(2014). Currently twenty-eight states require insurers providing contraceptive coverage to cover the full-range
of FDA-approved contraceptive drugs and devices. Twenty states allow some exceptions (states vary with how
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and the government, allowing women with either private or public insurance to more
easily and fully access OC. For women falling outside these categories, the ACA originally
mandated that states expand Medicaid access to people with incomes falling within one
hundred thirty-two percent of the poverty level, to hopefully provide public insurance
to these women.16 This provision could have been helpful to balance the uneven benefit
of reducing costs only for existing insurance holders. The Supreme Court's decision in
National Federation of Independent Businesses ("NFIB ") v. Sebelius, however, prevented
the complementary expansion of the Medicaid program, by refusing to make such an
expansion mandatory for states to implement, meaning that access remains uneven across
income levels. 7
As it stands, in terms of OC access, the ACA mainly benefits women with
existing access to an employer-sponsored insurance plan,58 and it does not address the
nonmonetary costs of OC under a prescription system. 9 Initial implementation of
the ACA has resulted in an increase in the number of privately insured women paying
nothing for OC from 15% to 40%.60 Neither the percentage of publicly insured women
paying nothing for OC nor the percentage of women who are uninsured paying nothing
permissive these exceptions are) to compliance with the contraceptive mandate and eight states do not permit
any exceptions. STATE POLICIES 1N BRIEF, at 2. These exceptions vary from limited, only allowing churches
and church associations to claim exemptions, to expansive, allowing religious organizations, including some
hospitals--one state exempts secular organizations as well. Id.
56 SONFIELD ET AL., supra note 3, at 30.
57 Nat'l Fed'n of Indep. Bus. v. Sebelius, 132 S. Ct. 2566, 2566 (2012).
58 The ACA leaves in place the United States employer-sponsored insurance system. This system began to
develop in the 1930s but has received much criticism. This system not only makes large corporations major
players in the health care system, but it also leaves Americans dependent on them for their health care needs.
See KANT PATEL & MARK E. RUSHEFSKY, HEALTH CARE POLITICS AND POLICY IN AMERICA 27 (2014). Employer-
sponsored because, although individuals now must have a plan, if it is not sponsored by an employer, the
individual is still spending more money than they would have without insurance. Even if they are not specifically
paying for birth control, they are not saving costs because their out-of-pocket expenses have increased.
59 Scout Richters, Note, The Moral Interception of Oral Contraception: Potential Constitutional Claims
Against the FDA Prescription Requirement for A Progestin-Only Birth Control Pill, 22 J.L. & POL'Y 393,
404-05 (2013).
60 Lawrence B. Finer et al., Changes in out-of-pocket payments for contraception by privately insured
women during implementation of the federal contraceptive coverage requirement, 89 CONTRACEPTION 97, 97
(2014).
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for OC has changed.61 Unemployment remains a major reason why individuals are not
insured.6 2 Similarly, while young women are allowed to stay on their parents' health
insurance plans until the age of twenty-six, this does not guarantee that they have access to
a full range of reproductive services. A young woman may have difficulty accessing OC on
a parental plan, if she and her parents have differing views on contraception. 63
The ACA also leaves the nonmonetary costs of accessing OC unaddressed.64 For any
woman, and especially for a woman who is a single mother, a woman working several
part time jobs, or a woman who is trying to complete a degree, prescription access's
nonmonetary costs are significant. Leaving such costs in place threatens potential societal
benefits for increased access to OC.
Even if the main purpose of the ACA was to reform health insurance,65 the unequal
way it affects OC costs for different women is detrimental to reproductive freedom.
Furthermore, "[e]xpanding the rights of the insured while at the same time limiting
contraceptive options with such devices as '[p]arental consent laws, for-profit health care,
welfare reform policies, and immigration policies impact[s] women's health choices and
detrimentally affect[s] the quality of care available. '66 While this particular concern was
articulated in the context of contraceptive equity laws passed by states like California and
Georgia, the ACA essentially implements the same policy 67 in terms of OC access, and "[i]
n securing expanded coverage for insured Americans, the privilege of having insurance and
the intersection with gender, socioeconomic, and racial or ethnic characteristics amplify the
61 Id. The prevention of Medicaid expansion prevented women on public insurance plans from fully
benefitting from these provisions. See Sebelius, 132 S. Ct. at 2566.
62 KAISER FOUND., KEY FACTS ABOUT THE UNINSURED POPULATION 2 (2013), https ://kaiserfainilyfoundation.files.
wordpress.com/2013/09/8488-key-facts-about-the-uninsured-population.pdf [http://penna.cc/5XDD-ZS5L].
63 See Hartz, Note, supra note 3 (noting also that young women who are still on their parents' health
insurance will not have access to abortion coverage).
64 Hartz, Note, supra note 3.
65 Key Features of the Affordable Care Act by Year, supra note 54.
66 McCandless, Note, supra note 3, at 1116-17 (quoting Loretta J. Ross et al., Just Choices: Women ofColor,
Reproductive Health, and Human Rights, in POLICING THE NATIONAL BODY: RACE, GENDER, AND CRIMINALIZATION
147 (Jael Silliman & Anannya Bhattacharjee eds., 2002)).
67 The notable difference simply being that the ACA will not allow insurance companies to pass on the cost
of birth control through the cost of the plan, which was a loophole allowed under contraceptive equity laws. Id.
30.1 217
218 COLUMBIA JOURNAL OF GENDER AND LAW 30.1
deficiencies of the underprivileged, including the uninsured."68 This problem is specifically
applicable to OC access.
In other words, the ACA's contraceptive provision and its continued reliance on
employer-sponsored health care69 create distinct challenges for OC access that vary based
on individual, overlapping characteristics. 70 While there is considerable policy concern
over women's reproductive issues, as well as concern over immigration, unemployment,
68 Id. at 1133-34.
69 Like most aspects of the American health care system, this is a complicated proposition. Some argue
that the ACA, because of its tax structure, will push employers away from offering plans to their employees,
moving many Americans to individual plans purchased on exchanges; at the same time others argue that
because the ACA did not fully equalize tax breaks for employer-sponsored and government exchange insurance
plans, companies will not fully move away from the employer-sponsored system. See, e.g., ACADEMY HEALTH,
THE AFFORDABLE CARE ACT AND EMPLOYER-SPONSORED HEALTH INSURANCE FOR WORKING AMERICANS 6-8 (2011),
http://www.academyhealth.org/files/nhpc/20 1 1/AH- 201 lAffordableCareReportFINAL3.pdf [http://perna.cc/
HZ3R-NZ3 8]; but see, e.g., Stuart M. Butler, Bye, Bye Employer Sponsored Health Insurance?, BROOKINGS
INST. Op. (Aug. 15, 2014), http://www.brookings.edu/research/opinions/2014/08/15-bye-employer-sponsored-
healthcare-butler [http://penna.cc/3 GFD-RJSV]:
By combining a cap on the tax-free status of employer-sponsored insurance with tax credits
and subsidies for exchange plans, the ACA takes some steps down the road of reducing the
tax bias associated with employer-controlled coverage. But the design of the ACA falls
short of what is needed. In an unwise effort to prop up the employment-based system and
to contain the program's budget cost, the ACA's sponsors flinched from equalizing the tax
breaks and subsidies for exchange plans and employer-sponsored health insurance. Yet that
tax and subsidy disparity actually threatens to undermine employer-sponsored coverage in
firms with many lower-paid workers. That's because the government subsidies available
for many such families enrolling in exchange plans are much larger than the tax benefits
of employer-sponsored insurance, encouraging employers and workers to drop employer-
sponsored insurance in favor of extra cash earnings.
Regardless of how the system evolves in the next few decades, for the moment, employer-sponsored
health insurance remains dominant.
70 This relates to intersectionality theory. See Kimberld Crenshaw, Mapping the Margins: Intersectionality,
Identity Politics, and ViolenceAgainst Women of Color, 43 STAN. L. REv. 1241, 1245 (1991) (defining structural
intersectionality). The particular complexity of how the ACA creates difficulties for individual women of
intersectional identities is difficult to pin down, given how these difficulties can vary across incomes and
location, in addition to identity components like gender and race, although McCall suggests that it is possible
to measure them. See McCall, supra note 22 at 1787-91. As far as the scope of this paper is concerned, it is
sufficient to state that these complexities require a more flexible system than prescription-only access, less tied
into structural inequalities. For a discussion of how OTC OC access is a more flexible system, see infra Part III.
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or education, rarely are these facets fully considered together.71 The ACA granted increased
benefits to insured women, but not all groups of women are insured at equal rates. 32% of
the 47.3 million uninsured Americans are Latino, while 19% are Black. 2 3 0.4 % of Latinos
and 32% of Alaska Natives and American Indians in the United States are uninsured,
compared with 12.7% of white people and 17.8% of Black people. 3 Unequal insurance
rates, under the ACA's provisions, correspond with unequal access for OC.
Language and legal status largely factor in as well. Barriers to communication,
stemming from differing language, but also differing cultural perceptions, make certain
women's experience with OC access wholly different. It is more difficult for women
whose primary language is not English to communicate effectively with some health care
providers to obtain a prescription for OC, and, in the United States, this particularly affects
Latina women.74 Undocumented women, additionally, are not affected in the same way
as other women.75 Without access to Medicaid or an employer's health care plan, which
71 For a full explanation of the shortcomings of research on these interplays and an explanation of how
the employer-based insurance system creates disparities for women with these characteristics, see supra
Parts 1.B-C.
72 KEY FACTS ABOUT THE UNINSURED POPULATION, supra note 62. That statistic is just out of the 47.3 million
people who are uninsured.
73 Health of Hispanic or Latino Population, CTR. FOR DISEASE CONTROL & PREVENTION, http://www.cdc.gov/
nchs/fastats/hispanic-health.htm [http://perma.cc/RJT5-VCMA] (last accessed Feb. 3, 2015); Health of White
Non-Hispanic Population, CTR. FOR DISEASE CONTROL & PREVENTION, http://www.cdc.gov/nchs/fastats/white-
health.htm [http://perma.cc/N7Wl-NC9W] (last accessed Feb. 3, 2015); Health of Black or African American
Non-Hispanic Population, CTR. FOR DISEASE CONTROL & PREVENTION, http://www.cdc.gov/nchs/fastats/black-
health.htm [http://perna.cc/T5ZD-YB5N] (last accessed Feb. 3, 2015).
74 Shelly Campo et al., It Isn t All About Language Communication Barriers for Latinas Using
Contraceptives, J. TRANSCULTURAL NURSING 1 (2014). The second most common primary language in the United
States is Spanish, which means that this problem affects Latina women, as a group, more prevalently than
others. CAMILLE RYAN, U.S. CENSUS BUREAU, LANGUAGE USE IN THE UNITED STATES: 2011 AMERICAN COMMUNITY
SURVEY REPORTS (2013), https://www.census.gov/prod/2013pubs/acs-22.pdf [https://penna.cc/AA69-83C8].
75 Difficulties in communication could include needing an interpreter, for appointments with doctors
who don't speak English, or miscommunications if either the doctor or patient is speaking in a secondary
language. Further, for doctors who are not native Spanish speakers or for women who are not native English
speakers, communicating about reproductive decision-making can present tricky language baffiers. See
Contraceptive Equity, NAT'L LATINA INST. FOR REPRODUCTIVE HEALTH, http://latinainstitute.org/en/what-we-do/
contraceptive-equity [http://perna.cc/ED5G-N2P7] (last accessed Feb. 3, 2015); Kimberly Inez MacGuire,
Increased Health Risks for Latina Women Don't Stop at the Border, HUFFINGTON POST (May 16, 2014, 11:47
EST), http://www.huffingtonpost.com/kimberly-inez-mcguire/increased-health-risks-fo b 5338150.html
[http://perma.cc/797C-EFKC].
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would come with legal employment, the barriers to access for OC are much more than
simply the time cost of a doctor's visit. Geography is another factor that further magnifies
the disparate impact of the contraceptive mandate. Often people are not in charge of their
own mobility-factors outside their control, like poverty or unemployment, can be very
limiting76-and so some individuals end up in areas where there is less access to reproductive
services or doctors who can prescribe OC. This is truer in rural areas compared to cities.77
The way the labor market is currently set up exacerbates these selective barriers to
OC access as well. Income contributes to the problem by determining those who are able
to have insurance in the first place. Thirty-eight percent of the uninsured have a family
income of less than the federal poverty level, and thirty-one percent are within two hundred
percent of the federal poverty level.78 This statistic is unsurprising, given that the ACA was
originally meant to extend Medicaid to cover at least some of these individuals but could
not under NFIB v. Sebelius.79 Data suggests that the employer-sponsored insurance system
itself effectually discriminates against women, as jobs that offer health care benefits are
not allocated equally between males and females,80 meaning that women have less access
to health insurance on the whole. Women also tend to have less continuous careers than
men do, which often disrupts their insurance coverage. 2 Finally, as women in heterosexual
relationships are more often the ones who choose not to work outside the home while their
76 PATEL & RUSHEFSKY, supra note 58, at 224.
77 PATEL & RUSHEFSKY, supra note 58, at 224.
78 KEY FACTS ABOUT THE UNINSURED POPULATION, supra note 62, at 206-09; see also PATEL & RUSHEFSKY,
supra note 58, at 209. Data also reveals that lower-paying service jobs are much less likely to offer insurance
than comparably paid manufacturing jobs. As the United States economy becomes more focused on service
professions, the amount of jobs with employer-sponsored plans shinks. Similarly part-time jobs generally
do not offer insurance and rarely offer insurance for spouses or dependents. Additionally, smaller firms also
struggle to fund the cost of health insurance for employees. This all contributes to individuals with lower
incomes being less likely to have an employer-sponsored health plan and less likely to then have access to OC
without any out-of-pocket costs.
79 Nat'l Fed'n of Indep. Bus. v. Sebelius, 132 S. Ct. 2566, 2566 (2012).
80 39.4% percent of women who work have insurance, compared to 51.5% of working men. PATEL &
RUSHEFSKY, supra note 58, at 219.
81 Nancy S. Jecker, Can an Employer-Based Health Insurance System Be Just?, 18 J. HEALTH CARE POL.
POL'Y & L. 657, 657 (1993). For an explanation of the theory, see PATEL & RUSHEFSKY, supra note 58, at 206.
82 PATEL & RUSHEFSKY, supra note 58, at 219.
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partner does, divorce can disrupt insurance coverage as well.83 The ACA's contraceptive
mandate perpetuates these issues, by tying contraceptive access to the employer-sponsored
health insurance system.14 Leaving the employer-sponsored insurance system in place
also allows insurers to retain substantial market power over drug pricing-this could
potentially affect the competitiveness of a market for OC, if an OTC system existed along
with prescription access. 5
Presciption-only access for OC based on an employer-sponsored insurance system
could also hurt women living with intimate partner violence, reproductive coercion,86 or
contraceptive sabotage. 7 In situations where a woman depends on her partner for insurance
coverage, the prescription-only system means that her partner has something of a say in
her contraceptive decisions. At the very minimum, the partner will know, from insurance
disclosures, about doctor's visits and OC prescriptions. A violent partner can more easily
coerce reproductive decisions if they have this information. As such, tying access to OC to
prescriptions could negatively impact women living in these situations.
Despite these real issues with how the ACA's contraceptive provision interacts with
other societal forces, the public controversy surrounding the law was not focused on these
phenomena.8 NFIB v. Sebelius greatly divided the country over the issue, and because of
83 PATEL & RUSHEFSKY, supra note 58, at 219.
84 But see PATEL & RUSHEFSKY, supra note 58.
85 See infra Part IV.A for a detailed discussion of this possibility and how to prevent it.
86 For background on reproductive coercion, see AM. COLLEGE OF OBSTETRICIANS & GYNECOLOGISTS,
REPRODUCTIVE AND SEXUAL COERCION 1 (2013), http://www.acog.org/-/media/Committee-Opinions/Committee-
on-Health-Care-for-Underserved-Women/co554.pdfdmc=l &ts=20150303T 1110232282 [http://perna.cc/
94DH-TYDF].
87 For background on contraceptive sabotage, see Leah A. Plunkett, Contraceptive Sabotage, 28 COLUM. J.
GENDER & L. 97, 102-07 (2014).
88 At this point, I would like to note the issue of long acting reversible contraceptives ("LARC"). Many
reproductive rights activists, as well as medical professionals and healthcare providers, have endorsed these
contraceptive mechanisms, as more effective than birth control. See, e.g., AM. COLLEGE OF OBSTETRICIAN &
GYNECOLOGISTS Comm., ACOG COMMITTEE OPINION No. 450: INCREASING USE OF CONTRACEPTIVE IMPLANTS
AND INTRAUTERINE DEVICES To REDUCE UNINTENDED PREGNANCY (2009), http://www.acog.org/Resources-And-
Publications/Committee-opinions/Committee-on-Gynecologic-Practice/Increasing-Use-of-Contraceptive-
Implants-and-Intrauterine-Devices-To-Reduce-Unintended-Pregnancy [http://penna.cc/E9CM-W8G6]. This
raises the question whether a push for OTC OC would similarly remove needed focus from LARCs. In
response, OC, while less effective than LARCs, can provide a somewhat different set of benefits than LARCs
can, which may appeal to certain women over others. First, OC can provide contraceptive benefits, but it can
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the way the issue was framed, supporters of reproductive freedom largely backed increased
insurance coverage.89 This increased reliance of women on both insurance and their
employer for birth control pills. At the same time, those who support limiting women's
access to contraception and abortion in general came out strongly in favor of leaving
responsibility on individuals.9" A health care system based on autonomy and freedom
in reproductive decision-making would ideally allow women full access to OC, without
having to consider or rely on the religious beliefs of their employers. Neither side of the
debate surrounding NFIB v. Sebelius comports fully with that idea, and the polarization
the ACA caused has created an environment where discussing viable solutions to these
issues is difficult.91 Moreover, increasing contraceptive access within insurance plans is not
relevant for millions of uninsured women in the US and has resulted in highly polarized
public opinion on the matter. Decreasing the rate of unintended pregnancies requires a
broader policy solution. 12
In light of the drawbacks of the current contraceptive access system, two overarching
solutions have been proposed to address them-a fully nationalized healthcare system or
a much more modest proposal of OTC OC. Moving to a more nationalized health care
system would make it easier to address inequity at a more basic level, but currently it would
likely not get the needed political support,93 based on the national reaction to the ACA
itself. So then the question arises as to whether OTC access is a workable solution.
III. Why Would Over-the-Counter Access Be An Improvement?
OTC access for OC is a feasible policy change that would ameliorate a substantial
portion of the problems with prescription-only access described in the last section for
several reasons: (1) OTC access for OC directly addresses the structural issues of the
also help regulate periods or treat acne, two effects some LARCs do not provide. Second, LARCs require a
medical procedure for insertion, and they can cause several side effects that some women may want to choose
to avoid. As such, OC is important in its own right and deserves the expenditure of some political will to move
it to an OTC system.
89 Nat'l Fed'n of Indep. Bus. v. Sebelius, 132 S. Ct. 2566 (2012).
90 See infra Part IV.B.
91 How this controversy has led Republicans to propose a premature OTC plan that would actually hurt
access is discussed in Part V.C of this Note.
92 McCandless, Note, supra note 3, at 1138.
93 McCandless, Note, supra note 3, at 1139.
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ACA's OC access system; (2) OTC access for OC protects women's autonomy over
reproductive decisions, as it is a medically safe option that women would use accurately
without supervision and that women want to use without supervision; and (3) the examples
of OTC emergency contraception in the United States and OTC access to OC in other
countries support that the proposition is a workable one.
A. Over-the-CounterAccess Addresses Structural Issues Created by the ACA.
Legalizing the ability to purchase OC OTC will make the ability to access it more
equal among United States women. Having an OTC system means that any woman with
access to a pharmacy-not only those with access to doctors or reproductive services
clinics-would be able to purchase OC.9 4 This would greatly increase the use of OC, as
"[m]any women.., stated they were likely to use contraceptives like birth control pills if
they did not need a prescription."95 Being unemployed or undocumented would no longer
prevent access to OC, provided OTC prices for OC are competitive.96 As such, the women
who could benefit most from OC, and who state the most reasons for seeking to obtain it,
would actually have equal access.
OTC access would also greatly reduce the existing nonmonetary costs of OC under
the ACA. Nonmonetary costs, like scheduling an appointment, taking time from work or
other responsibilities, answering personal questions, and finding a pharmacy that works
with their insurance plan (for insured women) or finding a reproductive clinic that will
serve them (for uninsured women) would all be reduced through OTC access.97 Also,
women would not need to have their prescription for OC renewed once a year, removing
yet another hurdle.98 Lessening these barriers would also increase women's consistency
94 McCandless, Note, supra note 3, at 1139-41.
95 McCandless, Note, supra note 3, at 1140 (citing PHARMACY ACCESS PARTNERSHIP, NATIONAL SURVEY ON
ATTITUDES AND INTEREST FOR PHARMACY ACCESS FOR HORMONAL CONTRACEPTION AMONG WOMEN AT RISK FOR
UNINTENDED PREGNANCY 8, 10 (2004) (63% of women in a household survey said that they would)).
96 See infra Part IV.A for a discussion of why high costs of OTC OC are not likely to be an issue.
97 Richters, Note, supra note 59, at 407.
98 As is currently required by United States law. See Birth Control Pill, PLANNED PARENTHOOD,
http ://www.plannedparenthood.org/health-info/birth-control/birth-control-pill [http ://perna.cc/3RYZ-PW5U]
(last accessed Jan. 2, 2015); but see Video Visit, PLANNED PARENTHOOD, http://www.plannedparenthood.org/
get-care/online/video-visit [http://perna.cc/YZ7Y-Z9WC] (last accessed Jan. 2, 2015) (Planned Parenthood
clinics in Washington State and Minnesota are making renewal visits accessible by video conference, thereby
significantly reducing nonmonetary costs, while retaining the prescription system).
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of OC use.99 OTC access would further benefit women in situations of intimate partner
violence, reproductive coercion, or contraceptive sabotage.1"' By alleviating dependence
on insurance, OTC access would allow women with a violent partner to make decisions
about OC without the partner knowing. Removing this information from insurance
disclosures and also removing the need to take time off work to see a doctor would make a
violent partner less able to sabotage. With an OTC system, women would be able to obtain
replacement OC, if they are sabotaged, although that is leaving aside an added cost. The
need to negotiate condom usage with a violent partner would also decrease with increased
access to OC OTC.10 1
The issue of how the ACA's contraceptive mandate intersects with income, race,
primary language, age, or geography to block certain women's access is not as easily cured.
As mentioned earlier, some women with potentially marginalizing characteristics seem to
have benefitted less from OC in the past. They not only have a harder time accessing OC
under the current prescription-only system, but even when they are able to access it, they
are less able to collect the long-term benefits of OC. 10 2 OTC OC access will not necessarily
allow women who face these barriers to overcome them, as there are more structural factors
at play. What it will do, though, is move access to OC outside of the employer-sponsored
health care system, which creates certain inequities in its own way.103 Additionally, as
women on the margins report more reasons for using birth control pills, increased OTC
OC access will have different effects for them, compared with benefits that are more often
reported. 104 The bottom line is that OTC OC access would not be harmful, unless its price
99 Amanda Dennis & Daniel Grossman. Barriers to Contraception and Interest in Over-the Counter Access
Among Low-Income Women: A Qualitative Study, 44 CONTRACEPTION 84 (2012).
100 See supra notes 86-87 and accompanying text for a description of the problems created by prescription-
only access for these women.
101 The one caveat to these benefits is that, if women did not need to visit a health care provider to obtain
OC, health care providers might be less able to screen for abuse. The ACOG's answer to these concerns is that
a yearly health care provider visit is recommended anyway to screen for these types of abuses, as well as to do
a preventive check for other health problems. See infra note 119 and accompanying text.
102 See supra notes 21-24 and accompanying text.
103 See supra notes 71-77 and accompanying text.
104 More often because studies that have been done already have not considered sufficiently women on the
margins and how their benefits can differ. See supra notes 22-25 and accompanying text.
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were too high for most women to realistically purchase.10 5 If the price is reasonable,10 6
though, at least some of the structural barriers to OC will be removed for all women. This
is an overall improvement compared with the current structure under the ACA.
B. Over-the-Counter Access Protects Women's Autonomy Over Reproductive
Decisions.
OTC availability for OC would increase women's perceived and actual bodily
autonomy. Women will reasonably construe a system that highly regulates and restricts
use of OC, despite the fact that OC is acknowledged to be safe without a health care
provider's opinion, I1 7 as a system that does not respect their autonomy over their own
bodies and reproductive decisions. The contraceptive mandate supports ideas of autonomy
and reproductive freedom for women by reducing the cost of OC, which in turn allows
some women more control over their own contraceptive decisions.108 But, overall, it still
restricts OC and leaves in place nonmonetary barriers to access. By reducing these barriers,
reproductive autonomy would be advanced.
1. Women Will Properly Self-Diagnose and Utilize Birth Control Pills
Over-the-Counter.
In order for OC to be safely sold OTC, the FDA requires that OC not be toxic in the
event of an overdose, not be addictive, and allow women to properly self-prescribe whether
birth control pills would be appropriate. These first three criteria are easily satisfied for
OC.i09 The FDA, though, also requires that women be able to take birth control pills without
a health care provider's instructions and be able to identify whether birth control pills pose
any particular, individual risk.110 These other two requirements raise answerable questions
about how women could self-diagnose and follow through on usage of OC. Studies about
how accurately and efficiently American women would be able to do both of these indicate
105 See infra Part IVA.
106 See infra notes 170-174 and accompanying text.
107 COMMITTEE OPINION No. 544: OTC ACCESS, supra note 4.
108 Hartz, Note, supra note 3.
109 Hartz, Note, supra note 3.
110 Daniel Grossman, Michael Cackovic & Michael J. Paidas, Viewpoints: Should Oral Contraceptives be
Sold Over-the-Counter, CONTEMP. OB/GYN, Sept. 2008, at 63-74.
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that in all likelihood women would self-prescribe and use OC on their own without issue in
the large majority of cases.111 As such, OTC access could be implemented to greatly reduce
nonmonetary costs of access without harming important public safety goals.
a. Self-Prescription Would Be Safe.
The first public health issue relevant to OTC access is whether women would be able
to safely assess their own eligibility to utilize OC. Birth control pills are widely considered
safe for most women, except for those who have certain risk factors. 112 For OTC access to be
safe, women with these risk factors, called contraindications, would need to accurately self-
identify them and refrain from purchasing and using OC once they are identified. Research
shows that self-identification of contraindications would not be a problem if women are
provided proper packaging and accompanying information for OTC OC purchases.
A 2006 study compared a self-evaluation survey given to women to an identical
questionnaire given to their health care provider regarding medical eligibility for OC.
Participants' assessments agreed with their providers' at or above 90% of the time for 17
out of 20 eligibility questions.113 The lowest percentage of agreement was for "Do you
usually get your period every month?" and that was 83.6%.114 Despite these very high
levels of agreement, a potential limitation to the study is that it failed to survey women who
do not speak English, which leaves out a segment of the female United States population
on the margins who might be most likely to benefit from OTC access.11 A remedy for this
potential issue would be public informational campaigns, including information in Spanish
and other widely spoken languages, and including comprehensive information on birth
control pills' packaging, to ensure women picking them up at pharmacies are aware of
relevant considerations. This measure would be in addition to ensuring that birth control
would be packaged with a similar questionnaire as utilized in the study, to allow women to
easily complete their self-evaluation.
111 See, e.g., Solmaz Shotorbani et al., Agreement Between Women and Providers 'Assessment offHormonal
Contraceptive Risk Factors, 73 CONTRACEPTION 501 (2006).
112 Hanna Xu et al., Medical contraindications in women seeking combined hormonal contraception, 210
Am. J. OBSTETRICS & GYNECOLOGY 210.el (2014) (finding that 97.62% of women had no contra-indications and
could safety take OC).
113 Shotorbani et al., supra note 111, at 501.
114 Shotorbani et al., supra note 111, at 503.
115 See supra note 74 and accompanying text.
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Additionally, in a 2010 study, the 48% of participants who thought that oral
contraceptives were not safe for them were just as likely to be medically eligible for birth
control pills as the participants who thought that they were eligible. 1 1 6 This indicates that
women tend to be overly cautious about their self-prescription, rather than the reverse.
Further, legalizing OTC access to oral contraceptives could contribute to an increased
perception that birth control pills are generally safe for most women to use.117
Perhaps most tellingly, in 2012 the American College of Obstetricians and Gynecologists
("ACOG") announced their support for OTC access for oral contraceptives, and they are
joined by the American Medical Association ("AMA").1 8 The ACOG identified certain
drawbacks and benefits to OTC access but concluded that the positives outweighed the
negatives. The ACOG considered the evidence of how women's self-assessments compare
with their health care providers' assessments of their eligibility for OC to conclude that OTC
access for birth control pills would be safe in this regard. The ACOG also contemplated
the importance of yearly oral contraceptive prescription visits for preventive cervical
cancer and sexually transmitted infections ("STIs") screening, only to conclude that oral
contraceptive visits do not technically require such screenings and the potential preventive
benefits do not outweigh the benefits of easier access.119 To further increase the accuracy of
self-analysis, the ACOG recommends utilizing a simple checklist system to allow women
to self-screen their eligibility for birth control usage.1 20 As such, the safety concerns of
self-prescribing are not a problem for liberalizing OTC access as a way to reduce women's
nonmonetary costs of OC.
b. Women Will Utilize Birth Control Pills Properly Without
Supervision.
A related but slightly different question is that of whether women would utilize birth
control pills properly without the yearly supervision of their health care providers. This
116 Daniel Grossman et al., Perceptions of the Safety of Oral Contraceptives Among a Predominantly Latina
Population in Texas, 81 CONTRACEPTION 254,254 (2010) [hereinafter Grossman et al., Perceptions ofOC Safety].
117 Jd.
118 COMMITTEE OPINION No. 544: OTC ACCESS, supra note 4; Adam Sonfield & Sneha Barot, Birth Control
Pills Should Be Available Over the Counter, But That No Substitute for Contraceptive Coverage, GUTTMACHER
INST. (Sept. 11, 2015), http://www.guttmacher.org/media/inthenews/2014/09/11 [http://penna.cc/R3BA-32J3].
119 COMMITTEE OPINION No. 544: OTC ACCESS, supra note 4, at 3 (recommending yearly preventive screening
visits regardless of birth control pill usage).
120 COMMITTEE OPINION No. 544: OTC ACCESS, supra note 4, at 3.
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is a particularly salient question because the effectiveness of this contraceptive method
depends so heavily on how consistently women use it. OC is more effective when used
consistently, 121 and ease of access promotes consistency of use. 122 Women express greater
willingness to utilize OC if they could access it OTC, which indicates that they may utilize
it more consistently as well. 123 The counterargument is that OTC access would assuredly
involve less oversight. However, there is no guarantee that the oversight under the current
system actually leads to more consistent usage.
In fact, a yearly health care provider visit does not necessarily ensure consistent usage
of OC and therefore should not be an obstacle to liberalizing access OTC. A 2014 study
determined that efficacy, actions, and attitudes of male partners, being in a long-term
relationship, experience with side effects, and misinformation or erroneous reasoning about
pregnancy risk were the most important indicators of how consistently women use birth
control. 124 This suggests again that visiting a health care provider is not very significant in
determining whether a woman will consistently use her birth control pills, and so should
not be considered a risk to liberalizing OTC access to birth control.
Prescriptions and visits to a health care provider not only do not increase consistency
of usage. In fact, the ACOG responds to concerns about decreasing consistency of usage 125
if OTC access is implemented by citing a study finding that women living in El Paso, who
were able to purchase OC OTC by travelling to Mexico, were more consistent in their usage
than other women in the United States, who obtained OC in packs containing multiple
121 Reed et al., supra note 36, at 245.
122 Reed et al., supra note 36, at 246:
To keep contraception consistent, a woman needs to go to the doctor, renew her prescription
before her supply of pills runs out, and remember to take pills daily. If she is relying on
condoms or withdrawal, she may need to be assertive with a partner to keep contraception
going. These somewhat burdensome behaviors are necessary for consistency.
123 See McCandless, Note, supra note 3, at 1140; cf Reed et al., supra note 36, at 256 (noting that efficacy
is helped by "[f]or those whose problem is low efficacy in remembering to schedule appointments on time,
provision of presciptions for more months of oral contraceptives so as to minimize needed follow-up clinic
visits would help.").
124 Reed et al., supra note 36, at 244 (including in the study all types of birth control, but holding consistent
for oral contraceptives).
125 COMMITTEE OPINION No. 544: OTC ACCESS, supra note 4 (citing K.O. White et al., Continuation of
prescribed compared with over-the-counter oral contraceptives, 118 OBSTETRICS & GYNECOLOGY 618 (2011)
(women given multiple pill packs tend to continue usage more than women who only receive one pack)).
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months' supply from a family planning clinic. 126 This finding suggests that OTC access,
with its lower nonmonetary costs, could in actuality encourage consistent use 127 -which
casts significant doubt on opposing arguments about needing prescriptions to encourage
women to take OC regularly.
One potential obstacle is American women's own attitudes, which could negatively
impact women's demand for OTC OC. A 2006 study determined that 63% of women felt
that OTC access for OC would be safe only if a pharmacist's screening were required before
purchase. 128 Additionally, in another study, women raised safety concerns for minors and
women with medical conditions using OTC contraceptives. 129 Despite this perception, as
earlier indicated, liberalizing OTC access would do much to increase women's perceptions
that birth control pills are a highly safe option.130 Women, on the whole, do not accurately
know what to do when they miss an OC pill.' To help mitigate this, packaging should
contain not only clear explanations of what the proper procedure for missed pills is,
but also a graphic illustration. 13 2 These measures should be seriously considered in the
implementation of an OTC system.
2. Women Want Over-the-Counter Access.
As with any reproductive policy question, whether women actually want OTC access
to oral contraceptives should be a primary consideration. The resounding answer found in
the data is yes, they do. Women's collective desire for OTC OC should lend considerable
weight to the push for making the option available. Too often, American reproductive
policy decisions have ignored women's autonomy.13 3
126 Joseph E. Potter et al., Continuation ofprescribed compared with over-the-counter oral contraceptives,
117 OBSTETRICS & GYNECOLOGY 551 (2011).
127 Id. at 556.
128 Landau, supra note 5, at 463.
129 Dennis & Grossman, supra note 50, at 84.
130 Grossman et al., Perceptions of OC Safety, supra note 116, at 254.
131 Lauren B. Zapata et al., Patient understanding of oral contraceptive pill instructions related to missed
pills: a systematic review, 87 CONTRACEPTION 674, 684 (2013).
132 Id. It is important, though, to balance provision of easily understood safety instructions with ensuring
that such instructions do not seem patronizing or overbearing.
133 See, e.g., Pa. Planned Parenthood of Se. Pennsylvania v. Casey, 505 U.S. 833, (1992); Alexis Ura,
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Empirical studies reveal just how popular OTC access would be. 68% of women in the
United States favor OTC access to OC.134 4 1% of those in favor were women who would
start to use OC if it were available in pharmacies, and women who are uninsured and
women with low incomes are proportionately more interested in OTC access.135 This result
correlates precisely with which women report the most to gain from OTC access to birth
control pills. 13 6 In another study, which indicated that 62% of United States women favor
OTC access to OC, being younger, being divorced or separated, living with an unmarried
partner, being uninsured, living in the South,137 currently using OC, or not currently using
any contraception were likely indicators that a women would support an OTC option.138
Further, 60.2% of non-oral contraceptive users in a study stated that they would be more
likely to use oral contraceptives if there were available over the counter-importantly, this
study was conducted among a mostly Latina population. 139
In a study of women utilizing a family planning clinic for abortion services, even
though only 42% indicated that they would use birth control pills after their abortion, 610%
said they would use them if they were available over the counter.140 Women who were
older than nineteen, were uninsured, had ever used oral contraceptives, had had difficulty
obtaining a prescription refill for hormonal contraceptives, or planned to use birth control
Appeals Judges Grill Lawyers Over Abortion Law, TEX. TRIBUNE (Jan. 7, 2015), http://www.texastribune.org/
2015/01/07/federal-appeals-judges-question-texas-abortion-law [http://penna.cc/AVP3-4YAM].
134 Landau, supra note 5, at 463.
135 Landau, supra note 5, at 463.
136 See supra Part I.C.
137 This is an interesting correlation, and it makes sense given how cultural attitudes towards reproductive
rights vary within the United States. Politicians from the South are more likely to oppose reproductive autonomy,
and Southern states on the whole have more restrictive legislation regarding abortion than other regions.
Given the likelihood of these politicians exercising their moral veto over reproductive options, understandably
women living in these states would want to ensure that they would be able to purchase OC OTC. See MARVIN
D. FELIT & BARBARA A. RiENZO, THE POLITICS OF YOUTH, SEX, AND HEALTH CARE IN AMERICAN SCHOOLS 111 (2002)
(stating that, at least for clinics treating students, "the South and Sunbelt regions, acknowledged to be the most
culturally traditional of the country, are home to 90% of the clinics offering the fewest sexuality services.").
For a discussion of how traditional morality impacts the social debate surrounding OC, see infra Part IV.C.
138 Daniel Grossman et al., Interest in Over-the Counter Access to Oral Contraceptives Among Women in
the United States, 88 CONTRACEPTION 544, 544 (2013) [hereinafter Grossman et al., Interest in OTCAccess].
139 Grossman et al., Perceptions of OC Safety, supra note 116, at 254 (again referencing a minority group
standing to benefit largely from such access).
140 Grindlay et al., Attitudes Toward OTCAccess, supra note 5, at 83.
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pills post-abortion were more likely to state that they would use OC if it were available
OTC. These characteristics comport those with which women also indicated were more
incentives for seeking birth control.141 At the same time, non-white women were less likely
than white women to state that they would use an OTC option. 142 This finding could make
sense, given that non-white women do not seem to benefit in the same ways as white
women do from access to OC; it is less clear how they do benefit, given the lack of studies
in this area. 143 It could also indicate a greater need for increased public information about
what OTC access for OC would do. Or, it could indicate that non-white women are more
concerned that OTC OC would be more expensive than prescription OC. 144
Going back to the choice of women living in El Paso, Texas, to either get a prescription
for birth control pills or purchase them over the counter in Mexico, helps illustrate women's
interest in OTC access for OC as well. 145 One study found that of the women who chose
to go to Mexico to obtain OC, 40% cited cost, while 27% cited avoiding going to a doctor
to get a prescription as their main motivation. 146 While women without any possibility
of OTC access to OC are satisfied with a clinic option, women with a realistic ability
to purchase OC OTC take advantage of it, citing both monetary and nonmonetary costs
as their motivation. 147 This further establishes that both types of costs influence women's
decisions about birth control pill usage. As for individual characteristics of those who
chose to go to Mexico for OTC access:
141 See supra notes 28-31 and accompanying text.
142 See supra notes 28-31 and accompanying text. This runs counter to other data stating that women on
the margins express a greater interest in OTC access-this could be a weakness in sample size, could indicate
a need to increase public education about the safety of birth control pills, or could be a result of how some
women do not currently have equal ease of access for OC. See supra notes 70-74 and accompanying text. If
the prescription-only ACA coverage system disproportionately impairs certain women, women of color and
Latinas in particular, from accessing OC, it is less likely that they will initially see an OTC system as markedly
different due to perceived economic issues (high price in particular) of switching to such a system. See infra
Part IVA.
143 See supra note 25 and accompanying text.
144 See infra Part IVC for a discussion as to why that should not be the case.
145 Over the counter access is legal in Mexico. Kate Grindlay et al., Prescription Requirements and Over-
the-Counter Access to Oral Contraceptives: A Global Review, 88 CONTRACEPTION 93, 93 (2013) [hereinafter
Grindlay et al., Prescription Requirements and OTC Access].
146 Joseph E. Potter et al., Clinic Versus Over-the-Counter Access to Oral Contraception: Choices Women
Make Along the US-Mexico Border, 100 AM. J. PUB. HEALTH 1130, 1130 (2010).
147 See id; Reed et al., supra note 36, at 256.
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Clinic users were younger than were pharmacy users, were somewhat
more likely to be single, to have fewer children, and to have somewhat
higher levels of education. Clinic users were also more likely to speak
English more fluently than they did Spanish and to have been born in and
completed their last year of schooling in the United States, but were less
likely to be frequent border crossers. Finally, clinic users were slightly
more likely than were pharmacy users to have received assistance from
US government poverty programs such as Women, Infants, and Children's
Program; Temporary Assistance to Needy Families; or food stamps. They
were more likely than were pharmacy users to have US health insurance
coverage, although coverage was extremely low for both groups, and
typically the plans did not pay for [oral contraceptives.] 148
The finding that pharmacy users were more likely not to have insurance is unsurprising,
but important, when considering how access under the ACA can be improved. The language
and birth country distinction supports the assertion that the current prescription-only system
imposes additional barriers on Spanish-speaking, Latina women who are not citizens. 149
This study indicates that OTC access for OC could help remove some of these selective
barriers. Further, the fact that women who have lower levels of education were more
likely to use the pharmacy option reflects the finding that women who have less education
would benefit more from being able to plan their pregnancies and correspondingly would
benefit more from increased accessibility of birth control pills-both of which increase
reproductive autonomy. 150 Their interest in OTC access is clear from this situation where
they realistically have this option because of their geographic location, as opposed to most
other women in the United States.
a. Successful Examples of OTC Access
Just as the example of border crossing demonstrates that OTC access to OC can
serve women well in the United States, the legalization of OTC access for emergency
contraception and the legalization of OTC access to OC in other countries also suggest that
an OTC system could be a success.
148 Potter et al., supra note 146, at 1035.
149 See supra notes 74-75 and accompanying text.
150 See SONFIELD ET AL., supra note 3.
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i. Example of Emergency Contraception
Legalizing OTC OC is often compared to the legalization of emergency contraception.
Understanding the shift from prescription-only to OTC for emergency contraception
elucidates, in some ways, how a similar shift of OC could occur. However, the two
medications have important distinctions that are important to consider when envisioning the
transition from prescription-only to OTC OC access. Although administrative procedures
were convoluted for emergency contraception's OTC legalization and costs rose, women's
usage of emergency contraception has increased as their access has increased-and this is
the relevant consideration for an OC comparison.
The administrative process for legalizing OTC access to emergency contraception was
long, drawn-out, and unusual.151 While the Center for Reproductive Rights first petitioned
the FDA to allow emergency contraception to be sold over the counter in 2001, the FDA
only legalized OTC sales in 2006 and only removed any age and point-of-sale limitations
in 2013.152 After the first petition by the Center for Reproductive Rights, a panel of FDA
experts approved emergency contraception, but the head of the office announced that normal
procedure would not be followed. He stated that the office needed to first reject the proposal,
then approve emergency contraception with an age limit in order to be politically viable. 153
A Government Accountability Office study conducted in 2005 officially determined that,
compared with the FDA's process of switching sixty-seven other drugs to OTC status, the
process it employed regarding OC was atypical.154
While emergency contraception is safe for teenagers,1 55 the FDA refused to make it
available to them until 2013 as mentioned. Political pressures seem to have influenced
this move, as HHS Secretary Sebelius personally blocked the FDA's approval of OTC
emergency contraception access for those under eighteen, and President Obama stood
151 U.S. GOVT ACCOUNTABILITY OFFICE, GAO-06-109, DECISION PROCESS TO DENY INITIAL APPLICATION FOR
OVER-THE-COUNTER MARKETING OF THE EMERGENCY CONTRACEPTIVE DRUG PLAN B WAS UNUSUAL (2005).
152 The Fight for Emergency Contraception: Every Second Counts, CTR. FOR REPRODUCTIVE RTS.,
http://reproductiverights.org/emergency-contraception-timeline [http://penna.cc/MMV8-NF2P] (last accessed
Jan. 25, 2015).
153 Id.
154 GAO-06-109, supra note 151.
155 Alastair J.J. Wood et al., The Politics of Emergency Contraception, 366 NEW ENG. J. MED. 101, 101-02
(2012).
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behind her decision. 156 On the one hand, these difficulties warn that switching OC to OTC
status could also come with strong political resistance. On the other hand, the FDA and
HHS staff might have learned that their attempted blocking of the emergency contraception
proposal was costly, resulting in litigation and investigation, 15 7 and OTC OC could therefore
be approved more easily.
However muddled the legalization process was, OTC access to emergency
contraception increased availability, although the impact of that increase is uncertain. As a
case study representing the trends that happened in the United States more broadly, in Iowa
the number of pharmacies carrying emergency contraception increased from 58% under
a prescription system, to 70% once the FDA implemented OTC access. 158 However, the
effect of this increase has not been unequivocally isolated. Some studies have found that
this increase in access decreased abortions in the relevant time period following the switch,
while others have found that it had no effect. 159 A 2014 study found that the main impact of
the increase in access was changing the location where most women obtained emergency
contraception, from hospital emergency rooms to pharmacies. This same study concluded
that this change actually resulted in fewer reports of sexual assault. Because women no
longer needed to visit the emergency room, they did not report their sexual assault in order
to get emergency contraception.160 Additionally, emergency contraception seems to have
slightly increased the instance of STIs among women aged fifteen to twenty-nine. 161
A final effect of switching emergency contraception to OTC access is that
while its cost on the whole to society decreased markedly, its price for individuals
156 The Fight for Emergency Contraception: Every Second Counts, supra note 152.
157 See GAO-06-109, supranote 141.
158 Melissa Lehan Mackin & Kathleen Clark, Emergency Contraception in Iowa Pharmacies Before and
After Over-the Counter Approval, 28.4 PUB. HEALTH NURSING 317, 317 (July/August 2011).
159 See Anjali D. Oza, Plan B as Insurance: The Effect of Over-the-Counter Emergency Contraception on
Pregnancy Termination and STIs (Oct. 2009) (unpublished manuscript on file with the University of Chicago
Harris School of Public Policy Studies) (finding that increased access for emergency contraception was
responsible for around 37.2% of the decrease in abortion between the years of 2005 and 2007); but see Tal
Gross et al., What Happens the Morning After? The Costs and Benefits of Expanding Access to Emergency
Contraception, J. POL'Y ANALYSIS & MGMT. 70 (Winter 2014) (finding that the switch had no statistically
significant influence on abortion rates).
160 Gross et al., supra note 159, at 86-88.
161 Oza, supra note 159.
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skyrocketed. 162 The cost for society decreased because when women had to obtain
emergency contraception in emergency rooms, this required the full cost of a hospital
visit, which can be very high. 163 OTC emergency contraception effectively eliminated that
expense. However, costs to individuals for emergency contraception increased because the
market was not fully liberalized. Emergency contraception was still available from health
care providers for no cost, which skewed OTC demand. 164
Despite some probable similarities, the negative side effects of increasing access
to emergency contraception are unlikely to transfer to OTC access for OC. Emergency
contraception usage differs significantly from OC because women are most likely to use
emergency contraception when they are unsure if they had safe sex. This same situation
is not associated with birth control usage, and so the effects will likely be similar but not
identical. 165 Emergency contraception is a reactive measure, while OC is a proactive one.
In practical terms, it is more common to use emergency contraception after unexpected
sexual encounters-that is, often, when a woman is not in a relationship.1 66 Additionally,
OC does not have the same relation to sexual assaults that emergency contraception does.
As such, the benefits of being able to plan pregnancies, or being able to plan on not being
pregnant, apply to increasing access to OC, whereas they would not apply to emergency
contraception. Politically, OC could be less problematic than emergency contraception, as
OC is less culturally divisive than emergency contraception. 167 Economically, OC is already
162 Dennis & Grossman, supra note 50, at 89.
163 The distinction here should be made between visits to emergency rooms by survivors of sexual assault,
and women who simply wanted access to emergency contraception after having had unprotected sex. Before
emergency contraception was available OTC, both required a visit to a hospital or doctor. For women who
simply wanted to obtain emergency contraception, the cost of a hospital visit was clearly unneeded and was
effectively eliminated once emergency contraception became available OTC. On the other hand, even with
OTC access, sexual assault survivors obtain emergency contraception from hospitals, and unfortunately high
costs can result, despite the Violence Against Women Act's protections for survivors. Kris van Cleave, For
some sex assault victims, ordeal carries price tag, CBS NEws (Nov. 12, 2014, 12:04 PM), http://www.cbsnews.
com/news/for-some-sex-as sault-victims-rape-kits-come-at-a-price [http://penna.cc/L5 G9-T8FJ].
164 Cf Ya-Chen Tina Shih et al., The effect on social welfare of a switch of second-generation antihistamines
from prescription to over-the-counter status: A microeconomic analysis, 24 CI NICAL THERAPEUTICS 701 (2002).
165 Tal Gross et al., supra note 159, at 75-76.
166 Whereas women in long-term, monogamous relationships are more likely to use OC. See supra note 34.
167 Abortion opponents believe that emergency contraception is, like an abortion, ending a life. While these
groups still do not approve of oral contraception, the reasoning is different. Oral contraception is seen more as
a facilitator for promiscuity, rather than akin to an abortion. For a discussion of the cultural issues surrounding
OC, see infra Part IV.C.
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marketed in the United States by fifty drug manufacturers, while emergency contraception
is marketed by only four,168 meaning that the market for OC would be substantially more
competitive than it was for emergency contraception. These important differences imply
that OC could transition to OTC status quite differently than emergency contraception. 169
ii. Comparative Legal Perspective: Examples from Other
Countries
A number of countries have successfully implemented OTC access for OC, providing
further evidence that a similar system could work in the United States as well. In fact,
the majority of the world lives in a country where birth control pills are available without
a prescription. 170 Despite this widespread access, nearly all Western European countries,
Canada, Australia, the United States, Japan, Saudi Arabia, and a few others still require a
prescription in order to use birth control pills. 171
Around the world, several different access models for birth control pills exist. There
are the two simple, but opposite, models of legal OTC access (24% of the world's
countries) and prescription access (3 1%).172 Then, there are countries where OTC access
is not technically legal, but the population and their government generally recognize that
pharmacies carry birth control pills (38%), and women regularly purchase them OTC.173
There are also countries where OTC access is legally allowed, but only with the added
requirement of a pharmacist's screening before purchase (80/%).174 Finally, a few countries
require a prescription to access birth control pills initially, but then allow OTC refills after
168 Directory of Hormonal Contraceptives, INT'L PLANNED PARENTHOOD FED., http://contraceptive.ippf.org/
search?search.searchtext=&search.component=&search.countrycode=US [http://penna.cc/PB9J-WGQ2] (last
accessed Feb. 20, 2015).
169 For a discussion of the differences and similarities of potential OTC pricing for OC compared to
emergency contraception, see infra Part IVA.
170 This includes both countries where birth control pills are legally sold over the counter and countries
where birth control pills are informally available in pharmacies, although there is no specific law authorizing
their sale there. Grindlay et al., Prescription Requirements and OTC Access, supra note 145, at 93.
171 Grindlay et al., Prescription Requirements and OTC Access, supra note 145, at 93.
172 Grindlay et al., Prescription Requirements and OTC Access, supra note 145, at 93.
173 Grindlay et al., Prescription Requirements and OTC Access, supra note 145, at 93.
174 Grindlay et al., Prescription Requirements and OTC Access, supra note 145, at 93.
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that.175 Compared with lower-income countries, high GDP countries, like those in Europe,
the United States, Australia, and Canada, are much more restrictive about how women can
legally access birth control pills. 176 South Asian countries generally have legalized OTC
access, South American countries mostly informally allow OTC purchases, and countries
in Africa have the greatest regional diversity in the type of access allowed. 177 As many
other countries have successfully legalized OTC OC, it seems that no comparative legal
issues indicate a potential issue with OTC access in the United States.
Higher-income countries have started to show signs of interest in switching to OTC
OC. London very successfully completed a pilot program of allowing OTC access for OC
to women and girls above the age of sixteen in April 2012. The results of the program
indicated that OTC access to OC reduced consumption of emergency contraception. 178 The
National Health Service concluded that
[t]rained community pharmacists are able to provide an oral contraceptive
service under a [Patient Group Direction]. The service has been largely
accessed by local women aged 20-24 years. Most consultations have been
with black British, Caribbean and African women, and 46% of initial pill
supplies have been to first time pill users .... Service users have valued the
service highly, in particular the convenience, anonymity, drop-in system,
long opening hours and lack of waiting time. Possible improvements
could be made to accessing the service and signposting from counter staff.
[Emergency contraception] has declined in the pharmacy providing the
most oral contraception. Local GP practices and sexual and reproductive
health services have referred clients to the service, and therefore opened
up the possibility of a future service model aiming to shift activity from
[prescription] services. 179
175 These countries include Botswana, the British Virgin Islands, Burkina Faso, New Zealand, and Zimbabwe.
Grindlay et al., Prescription Requirements and OTC Access, supra note 145, at 93.
176 Global Oral Contraception Availability, OCs OTC WORKING GROUP, http://ocsotc.org/wp-content/
uploads/worldmap/worldmap.html [http://perma.cc/ 4 LLL-R5S8] (last accessed Jan. 23, 2015).
177 Grindlay et al., Prescription Requirements and OTC Access, supra note 145, at 93.
178 Widen over-the-counter pill access, says NHS report, BBC NEWS (Apr. 25, 2012), http://www.bbc.com/
news/health- 17847069 [http ://perma.cc/AR8K-6A3X].
179 BRITISH NAT'L HEALTH SERV., SOUTH EAST LONDON, EVALUATION OF ORAL CONTRACEPTION IN COMMUNITY
PHARMACY PILOT IN SOUTHWARD AND LAMBETH 4 (2012), http://ocsotc.org/wp-content/uploads/2012/04/NHS-
2012 Evaluation-of-phannacy-provision-of-OCs-in-London- 1-2012.pdf [http ://penna.cc/W76K-2HBA].
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It is notable that emergency contraception use declined with the implementation of
OTC access for OC. This could prove more effective than a system where emergency
contraception alone is available without a prescription-effective because emergency
contraception usually indicates a reactive decision, whereas OC provides the benefit of
being able to plan in advance. Additionally, the women benefitting from this program
immediately cited, as a primary benefit, the reduction in nonmonetary costs that OTC
access provides, illustrating once again how great a barrier these costs actually pose. The
success of this pilot program, in a country similarly positioned economically and culturally
to the United States, suggests that the United States (and other higher income countries)
should implement OTC access as it is both practically feasible and effective.
IV. If Over-the-Counter Access Makes So Much Sense, Why Not Implement It
Immediately?
The findings above clearly demonstrate that women want OTC access to OC, and
moreover that OTC access would be safe, would address issues with the ACA's insurance
coverage-only system, would save both monetary and nonmonetary costs, and would make
birth control pills available for those women who would benefit most from its use. Yet
an immediate switch from the prescription system could have a number of downsides.
These include: (1) OC could increase women's out-of-pocket costs for OC, while saving
insurers money; (2) OC could become a partisan fight; and (3) cultural attitudes about
reproductive autonomy might inhibit effective implementation. There are ways to temper
these issues, though, and successfully implement OTC OC. Namely, HHS should require
Medicaid and insurance companies to reimburse women for OTC OC purchases, so that
women do not have to choose between convenience and out-of-pocket costs and so that
insurers are invested in a competitive OTC market. Additionally, the recent change in
Republicans' messaging regarding OC could signal a shift in the political and cultural
debate over contraception. This would be helpful for OTC implementation, particularly
through citizens' petitions to the FDA.
A. Economic Issues
Switching any drug, including OC, to being available OTC makes sense from an
economic standpoint when the social benefit of the switch outweighs any social cost. 180 In
economics, this is referred to as the net social benefit. This cost-benefit analysis differs from
an individual valuing whether or not the price of birth control pills is worth it to them. Net
180 Peter Temin, Costs andBenefits in Switching Drugs From Rx to OTC, 2 J. HEALTH ECON. 187, 187 (1983).
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social benefit takes into account both monetary and nonmonetary costs, assumes that all
individuals would face the same types of both costs (an assumption that does not bear out
in reality), and is based on potential benefit to "society" as a whole.181 Economists refer to
this societal benefit as "minimizing the deadweight loss" of a certain policy. 18 2 Calculating
the net societal benefit means comparing new benefits minus new costs with old benefits
minus old costs. If this difference is positive, the switch to over the counter access will be
beneficial because, overall, costs will be saved.183 Economic theory predicts that the price
of drugs switched to OTC access will be cheaper than they were under prescription-only
OTC access because more companies will enter the market to compete for new business and
that competition will lower prices. The lower prices, in turn, will then increase consumer
demand. Individuals who had initially been priced out of the prescription market will then
be able to enter and buy the drug. 18 4
There are a few characteristics that increase the chance that a switch to OTC access
will be a success, under this theory. Drugs that are not patented185 are better candidates for
OTC access because drugs that are still under patent protection will tend to be over-priced
as only a limited number companies are allowed to manufacture them. 186 More companies
producing the drug means more competitive pricing, which in turn reduces the deadweight
loss to society. Additionally, drugs that are offered only through OTC access, not both OTC
and prescription access, are also better candidates. Only being offered OTC will stabilize
both price and demand for the drug 187 and will ensure that the cost savings flowing from
181 See, e.g., Mandy Ryan & Brian Yule, Switching Drugs from prescription-only to over-the-counter
availability: Economic Benefits in the UK, 16 HEALTH POL'Y 233, 234-36 (1990); Temin, supra note 180.
182 Deadweight loss simply means any increased net cost resulting from a policy change, not transferred as
a benefit to another party. See, e.g., Temin, supra note 180.
183 See Temin, supra note 180.
184 Shih et al., supra note 164.
185 See Amanda Holpuch, Generic Emergency Contraception: Age Restriction to Remain in Place,
GUARDIAN: U.S. NEWS (July 24, 2013, 17:03 EST), http://www.theguardian.com/world/2013/jul/24/america-
generic-emergency-contraception-age-restriction [http ://perna.cc/B47A-RYXQ].
186 Shih et al., supra note 164, at 703.
187 Demand for drugs available both ways is said to be elastic-elasticity of demand describes how
responsive individuals' demand is to small changes in price. This means that, because someone could opt out
of the over-the-counter option by going to a doctor and getting a prescription for a drug, that would then be
covered by insurance, a small change in the price of a drug available both over-the-counter and by prescription
would lead to a relatively large change in demand. This makes the drug very susceptible to price shocks.
Conversely, a drug that is only available over-the-counter will be relatively inelastic because individuals who
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increased OTC demand goes to individuals purchasing the drug, as opposed to insurance
companies.188 Finally, drugs that do not have a large risk of harm caused by inappropriate
usage after self-diagnosis are better candidates for OTC access, because this decreases the
risk of a large cost being placed on a single individual.189
Oral contraceptives would be a good candidate for OTC access based on the above
criteria and would likely decrease in price after a switch to OTC availability. The AMA and
the ACOG have found that birth control pills do not pose a great risk from improper usage
for many women, and so this also decreases the potential of a huge cost of misuse, born by
only some individuals. 19 0 Birth control pills are not patent-protected, and there are generic
oral contraceptives readily available.191 This means that monopolistic pricing 192 would not
be as much of an issue for OC. Fifty manufacturers currently produce oral contraceptives
of varying kinds, and so competition for the OTC market would likely be robust.193 A
competitive market means low prices and high availability for OC. For example, allergy
medicine, although initially only available with a prescription, successfully transitioned
need the drug will have no choice but to purchase it from pharmacies. This means that small changes in the
price of the drug would have much less of an effect on demand. See, e.g., Shih et al., supra note 164.
188 Insurance companies stand to benefit most from a reduction in the cost to society that occurs when a drug
is moved to over-the-counter availability because they are the ones who no longer have to pay for health care
provider visits where the drug is prescribed, and, if the drug is not included in a plan provision covering over-
the-counter purchases, the individual would assume the cost of the drug itself too, whereas before the insurance
company would have been responsible. See Susan E. Andrade et al., The Effect of an Rx-to-OTC Switch on
Medication Prescribing Patterns and Utilization of Physician Services: The Case ofH2-Receptor Antagonists,
37 MED. CARE 434 (1999); Patrick W. Sullivan et al., Transitioning the Second-Generation Antihistamines to
Over-the-Counter Status: A Cost-Effectiveness Analysis, 41 MED. CARE 1382 (Dec. 2003).
189 This large cost would be the cost of dealing with injury or harm after an improper self-diagnosis. Social
cost analysis includes both monetary and nonmonetary costs, so medical care and pain and suffering would be
included. It would be a large and concentrated cost if there was a relatively low chance that a relatively large
harm would befall someone who improperly used an OTC drug. See Shih et al., supra note 164.
190 See COMMITTEE OPINION No. 544: OTC ACCESS, supra note 4; Sonfield & Barot, supra note 118.
191 Bayer Healthcare Pha-m., Inc. v. Watson Pharm., Inc., 713 F.3d 1369, 1369 (Fed. Cir. 2013) (holding
patent protection for oral contraceptives invalid for obviousness).
192 Monopolistic behavior refers to the phenomenon where, because only one or a few producers are in the
market for a certain good, they have disproportionate control over the price of their goods. A market that is
controlled by monopolistic pricing is said to be "noncompetitive."
193 See supra note 168.
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to OTC access and is commonly available, fairly cheaply, in local pharmacies. 19 4 It would
seem that the market for OTC OC would produce similar results. For a graphic depiction
of how a switch to OTC access would save societal costs, see Appendix A.
OC, like allergy medicine, in all likelihood would sell for reasonable prices on pharmacy
shelves. 195 According to a 2013 study of a representative national sample of women at risk
for unintended pregnancy, women are willing to pay approximately $20 per monthly pack
of birth control pills purchased over the counter, meaning that they would only pay $240
per year. 196 This estimate includes nonmonetary cost savings, as the women interviewed
are including in their calculations the increased ease of obtaining birth control pills when
they estimate that their maximum price is $20. Some generic birth control pills are already
available at self-pay prices of around $15 or $20 a month, 19 7 and liberalizing OC will only
drive down those prices further. As such, from a purely economic perspective, women are
likely to take advantage of the OTC option.
Despite this evidence, some critics assert that OTC birth control pills would only be
available at exorbitant costs,198 citing the high prices of emergency contraception when
194 Sullivan et al., supra note 188; see also Claritin Indoor & Outdoor Allergies, RITE AID PHARMACY,
https:/shop.riteaid.com/claritin-indoor-outdoor-allergies-original-prescription-strength- 1 0-mg-tablets-20-
tablets-0335007 [https://perma.cc/2PDY-QS7W] (last accessed Feb. 21, 2015) (twenty tablets available for
$18.99); Claritin Tablets 24 Hour Allergy, CVS PHARMACY, http://www.cvs.com/shop/health-medicine/allergy-
asthma/allergy-sinus-medicine/claritin-tablets-24-hour-allergy-skuid-210285 [http ://perna.cc/WSY9-FCY6]
(last accessed Feb. 21, 2015) (twenty tablets available for $19.79).
195 The only caveat could be that OTC prices could increase to accommodate OC manufacturers' concerns
about potential class actions. This seems unlikely to be a significant concern though because of how widely
used OC already is. The risk would therefore not increase substantially with an OTC switch.
196 Grossman et al., Interest in OTC Access, supra note 138, at 544. This is also making the assumption
that women would be happy with a generic OC, specifically for the purpose of preventing pregnancy. OC is
also currently prescribed for other purposes like regulating periods or controlling acne. These uses would still
require a health care provider visit and might result in a more specific demand for one type of birth control pill.
It also could result in an increased willingness to pay for a specific brand or dosage.
197 Price of the Pill, WNYC, http://project.wnyc.org/birth-control-prices/embed.html?layer=undefined
[http://perna.cc/S7YH-PQG8] (last accessed Feb. 21, 2015) (stating that the price of Aviane at a Rite Aid in
Manhattan would cost $19.99 a month for a self-pay patient).
198 See, e.g., Maria Liasson, Changing Tack: GOP Candidates Support Over-the-Counter Birth Control, NPR
SHOTS: HEALTH NEWS BLOG (Sept. 12,2014,3:30 EST) http ://www.npr.org/blogs/health/2014/09/12/347749930/
changing-tack-gop-candidates-support-better-access-to-birth-control [http://perma.cc/VSX9-P5Z5] (citing
Democratic pollster Cellinda Lake to say that OTC OC could cost "$600 per year").
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it was first made available OTC.199 There are several flaws in this comparison. First,
when emergency contraception was legalized for OTC access, it was still protected by a
patent. Plan B was the sole brand legally permitted to market emergency contraception in
pharmacies. The FDA only legalized sale of generic emergency contraceptives in 2014-
eight years after legalizing OTC sale of Teva Pharmaceutical's Plan B One Step. 2°° The
initial monopoly power of Teva was part of the reason for the increase in emergency
contraception's pricing. The competitive effects of legalizing generic sales have been
slow to take effect (generics are about $10 cheaper than Plan B)20 1 because of the way it
was initially legalized and because the FDA, as part of its earlier agreement with Teva,
insists on labeling generic emergency contraception as only for women above the age of
seventeen.20 2 Additionally, ten times as many manufacturers sell OC currently than sell
emergency contraception. 20 3 As such, there would not be the same monopolistic pricing
problem, preventing prices from becoming competitive, for OC. Second, in addition to
economic differences, emergency contraception and OC are utilized for different purposes,
meaning that women's purchasing patterns would be more consistent and demand would
also be larger for OC.204
There is a concern that if OTC OC access were legalized while a prescription option
was still available, and still covered by insurers, this could skew the market for OC.205 If
199 See, e.g., Amelia Thompson-Deveaux, Offering Birth Control Over the Counter Wouldn ? Make It Any
Cheaper, FIVE THIRTY-EIGHT POLITICS (Nov. 18, 2014, 7:10 EST), http://fivethirtyeight.com/features/offering-
birth-control-over-the-counter-wouldnt-make-it-any-cheaper [http://perma.cc/UB57-U7R3]; Sonfield & Barot,
supra note 118.
200 See Amanda Holpuch, Generic emergency contraception: age restriction to remain in place, GUARDIAN
(July 24, 2013, 17:03 EST), http://www.theguardian.com/world/2013/jul/24/america-generic-emergency-
contraception-age-restriction [http ://perna.cc/4BLJ-FM7N].
201 Compare Plan B One-Step Emergency Contraceptive, CVS PHARMACY, http://www.cvs.com/shop/
sexual-health/condoms-contraceptives/female-contraceptives/plan-b-one-step-emergency-contraceptive-
skuid-876669 [http://perma.cc/T5GW-ADRC] (last accessed Feb. 21, 2015) ($49.99), with CVS Take Action
Emergency Contraceptive Tablet, CVS PHARMACY, http://www.cvs.com/shop/product-detail/CVS-Take-
Action-Emergency-Contraceptive-Tablet?skuld=966195 [http://perna.cc/L6KC-4EDN] (last accessed Feb.
21, 2015) ($39.99).
202 Amanda Holpuch, supra note 200.
203 See supra note 168 and accompanying text.
204 See supra notes 142-143 and accompanying text.
205 This is based on the logic that drugs offered under a dual prescription and OTC system are likely to not
be completely competitive priced and to give insurance companies the benefit of reduced prices as opposed to
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the current relatively low cost of OC is driven by insurers' bargaining power with drug
companies, then insurers will require women to continue getting prescriptions to preserve
these insurers' advantage.2 °6 This effectively would save insurers money, as some women
would choose to pay the sticker price in their pharmacy instead of getting a prescription,
generating savings on both the cost of women's health care provider's visits and OC
itself.207 At the same time, women who could not afford OTC OC would continue relying
on insurance. 20 8 With this option still in place, there would be less demand than should
exist for the OTC option, and, as a result, suppliers would likely raise prices.20 9 This price
increase for OTC OC would hurt uninsured women most, who generally have no option
aside from OTC access.210
However, this model of insurers' bargaining power is not necessarily correct. OC
could simply be a relatively inexpensive drug. If this is true, insurers should not resist the
OTC system very strongly. HHS itself maintains that, as OC prevents the significantly
higher health care costs associated with unintended pregnancies, OC is in fact a cost saving
measure, rather than an expense. Justice Alito focuses on this issue in his Burwell v. Hobby
Lobby opinion,211 and research supports it as well. The Guttmacher Institute found that $1
consumers. See supra notes 161-162 and accompanying text.
206 Eric P. Brass, Changing the Status ofDrugsfrom Prescription to Over-the-Counter Availability, 345 NEW
ENGL. J. MED. 810, 815 (2001).
207 See id; PATEL &. RUSHEFSKY, supra note 58, at 262-63; cf Jessica Cohen et al., Price Subsidies,
Diagnostic Tests, and Targeting of Malaria Treatment: Evidence from a Randomized Controlled Trial
(Nat'l Bureau of Econ. Research, Working Paper No. 17943, 2012), http://www.nber.org/papers/w17943
[http://perma.cc/C6W7-XJH4] (detailing the success of government subsidies for high need drugs in a low-
income country).
208 Cf Bruce Stewart & James Grana, Are Prescribed and Over-the-Counter Medicines Substitutes?, 33
MED. CARE 487 (1995) (finding that when insurers will cover drugs with prescriptions, but not those OTC,
individuals will continue to go to the doctor for prescriptions).
209 Cf supra note 164.
210 Richters, Note, supra note 59, at 407.
211 134 S. Ct. 2751, 2781 (2014):
It seems likely, however, that the cost of providing the forms of contraceptives at issue in
these cases (if not all FDA-approved contraceptives) would be minor when compared with
the overall cost of ACA. According to one of the Congressional Budget Office's most recent
forecasts, ACA's insurance-coverage provisions will cost the Federal Government more
than $1.3 trillion through the next decade.... If, as HHS tells us, providing all women with
cost-free access to all FDA-approved methods of contraception is a Government interest of
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of public funding used for contraception saves $3.74 in pregnancy and maternal health care
expenses.212 Contraceptive funding also saves abortion costs. 213 Under this model, insurance
companies should rationally prefer to provide coverage for contraceptives, instead of later
dealing with higher medical costs.
Regardless of whether or not insurers will resist the switch, given that the ACA provides
some women OC without any out-of-pocket costs, these women will necessarily face higher
prices with OTC access. As a solution to this issue, HHS could change their policy so that
both Medicare and private insurance plans would be required to reimburse women for
their purchase of OC OTC.214 If insurance companies and Medicare were required to cover
the cost of OTC OC, first, women would not be individually responsible for paying out-
of-pocket, and, second, insurance companies and the federal government 215 would have a
vested interest in making sure the price of OTC remains competitive. Implementation of
this system would be technically easy. HHS currently specifies that insurance companies
must provide coverage for "all FDA approved contraceptive measures," "as prescribed. '216
If HHS included OC "purchased over-the-counter," this would effectively eliminate
women's out-of-pocket cost for that access option too.
In fact, Medicaid already incorporates coverage for OTC medicines, which could extend
to OC.217 Medicaid allows states to approve coverage of OTC emergency contraception
the highest order, it is hard to understand HHS's argument that it cannot be required under
RFRA to pay anything in order to achieve this important goal.
212 Adam Sonfield, The Case for Insurance Coverage of Contraceptive Services and Supplies Without Cost
Sharing, GUTTMACHER POL'Y REV. (Winter 2011), http://www.guttmacher.org/pubs/gpr/14/1/gprl4OlO7.html
[http://penna.cc/455K-AYAQ].
213 Jeffrey F. Peipert et al., Preventing Unintended Pregnancies by Providing No-Cost Contraception, 120
OBSTETRICS & GYNECOLOGY 1291 (2012).
214 See, e.g., Sonfield & Barot, supra note 118.
215 The federal government has a lot of clout in this arena because the government is the single largest
purchaser of health care in the United States, accounting for 29% of total expenditure. PATEL & RUSHEFSKY,
supra note 58, at 25.
216 Affordable Care Act Prevention Coverage Expands Women Health and Well-Being, HRSA,
http://www.hrsa.gov/womensguidelines [http://perma.ccNTW5-JGHS] (last accessed Jan. 30, 2015); see also
Kevin Drum, Should Liberals Support OTC Access to Oral Contraception?, MOTHER JONES (Sept. 9, 2011),
http://www.motherjones.com/kevin-drum/2014/09/should-liberals-support-otc-access-oral-contraceptives
[http://perma.cc/CWC7-QWU4].
217 Sonfield & Barot, supranote 18; NAT'L HEALTH LAw PROGRAM, OVER THE COUNTER OR OUT OF REACH? (2007),
244 30.1
COLUMBIA JOURNAL OF GENDER AND LAW
specifically if it is treated like a prescription. This, in most states, requires some kind of
verification from a health care provider, which has similar nonmonetary costs to an actual
prescription. However, several states, including New York, have waived this requirement.
Ensuring that no such requirement would come along with OTC OC would be crucial.
The catch is that the failure of the ACA's complementary expansion of Medicare provision
means, even if Medicare did reimburse women for purchasing OC OTC, there is still a
segment of women in need of that assistance who are not receiving it.
A temporary government price control could be useful to allow all women who want
to enter the market to do so. However, the United States, unlike many less developed
countries, does not implement drug price controls.218 The limitations Medicaid and
Medicare place on reimbursing health care providers for drugs are the closest the United
States comes to regulating drug prices. These limitations specify that government programs
will only reimburse patients for the cost of a generic drug, if a suitable one is available.
However, this is comparatively ineffective. The government, besides the Department of
Defense and the Veterans Affairs Administration, is not allowed to negotiate lower prices
with drug manufacturers, unlike insurance companies or hospital networks. 219 This is why
reimbursement is important for an effective OTC system. Otherwise, insurance companies
have no stake in lowering the price of OC overall, and the government would not be able
to do anything about it.
A contingency consideration is what happens if Republicans make good on their
campaign promise to attack the ACA. While President Obama is in office, Republicans
will not be able to repeal the Act. However, it is possible that the Republicans will be able
to significantly alter it.22° Also, looking to the next presidential election, the ACA's staying
http://www.healthlaw.org/component/j sfsubmit/showAttachment?tmpl=raw&id=00Pd00000077hMMEAY
[http://penna.cc/XR6S-MCLD].
218 See F.M. Scherer, The Pharmaceutical Industry Prices and Progress, 351 NEW ENG. J. MED. 927, 929-
31(2004).
219 This affords insurers large benefits in terms of price reductions, compared to the government. See id. at
929-31; PATEL & RUSHEFSKY, supra note 58, at 262-63; cf Cohen et al., supra note 207 (detailing the success
of government subsidies for high need drugs in a low-income country).
220 Most likely provisions to be candidates for reforms include the employer mandate, the individual
mandate, and the device tax that the ACA implements. Can the GOP Repeal the Affordable Care Act?, AL
JAZEERA AM. (Nov. 13, 2014), http://anerica.alj azeera.com/watch/shows/inside-story/articles/2014/11/13/can-
the-affordablecareactberepealedandreplacedbythegop.html [http://perma.cc/KZ5B-NYCU]. Another potential
way of challenging the ACA is through litigation, but, after the Supreme Court struck down a second challenge
to the law, this may be a less viable avenue. See King v. Burwell, 135 S. Ct. 2480 (2015).
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power into 2017 could be uncertain as well. If the contraceptive mandate is repealed,
and full OTC access implemented simultaneously, this could result in a fully competitive
market, but would also mean an increase in women's costs for OC out-of-pocket. This
means less access for all women, but particularly for those who are margialized. Such a
hypothetical underscores the need to expand insurance coverage for OC purchased OTC,
as a transition, as opposed to simply expanding access.
B. Political Issues
The fall of 2014, at first glance, seemed like an exciting time for advocates of OTC OC.
Republican United States congressional candidates began to voice their support for OTC
sales of birth control pills. It may have seemed like the beginning of widespread agreement
over increased reproductive freedom and access. A more careful look, however, reveals
that campaign promises of OTC access are fairly empty, as it is the FDA, not Congress,
who would make this decision. Further, immediate implementation of an OTC system
might not actually increase access to the extent that politicians have begun to claim.
Listening to Republican politicians suggests they have internalized all of the
information cited about the benefits of widespread access to OC for women's
general wellbeing. Republicans like Rep. Barbara Comstock (R-Va.), Rep. Cory
Gardner (R-Col.), Senate candidate for Virginia Ed Gillespie, Senate candidate for
Minnesota Mike McFadden, and Republican Senate candidate for North Carolina
Thom Tillis have recently come out in favor of legalizing OTC access for birth control
pills. 221 These candidates cite how the option would be safe, how this would lessen
government's interference with women's reproductive decisions, and how OTC access
would be more convenient.222
221 Anna Altman, Why Are Republicans in Favor of Over-the-Counter Birth Control?, N.Y TIMES Op. TALK
(Sept. 29, 2014, 6:10 EST), http://op-talk.blogs.nytimes.com/2014/09/29/why-are-republicans-in-favor-of-
over-the-counter-birth-control/?src-recg& r-0 [http://perma.cc/ABC7-BBSA]; Thomas M. Burton & Natalie
Andrews, New DiscordBrews on Over-the-Counter Contraceptives, WAIL ST. J. ONLINE (Sept. 10, 2014, 13:15
EST), http://www.wsj.com/articles/new-discord-brews-on-over-the-counter-contraceptives- 1410377872?cb
=loggedO. 8794443022925407 [http ://perma.cc/QG87-AAJG]; Barbara Comstock for Delegate,
http://www.comstockfordelegate.com/home.aspx [http://perna.cc/BL72-DL4V] (last accessed Jan. 25, 2015);
Sandhya Somashekhar, GOP Senate Hopefuls Favor Over-the-Counter Birth Control, WASH. POST, Sept. 2,
2014, at A3, available at http://www.washingtonpost.com/national/health-science/gop-senate-hopefuls-favor-
over-the-counter-birth-control/2014/09/02/1916bef2-32c0-1 le4-a723-fa3895a25d02_story.html [http://perna.
cc/55NA-A7LW]; Liasson, supra note 198.
222 Altman, supra note 221.
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Unfortunately, despite proposing ideas that advocates of reproductive freedom could
support, these conservative candidates' agendas are suspect. This list of candidates is not
known for its genuine attention to women's reproductive freedom. Most notably, Tillis
and Comstock were avid supporters of North Carolina's and Virginia's proposals requiring
pre-abortion transvaginal ultrasounds. 223 It is increasingly apparent that women voters
do not support candidates who restrict access to reproductive services, 224 and so these
candidates might be changing their message accordingly. Planned Parenthood has criticized
these proposals as shortsighted, citing the potential for OTC birth control pills' price to
skyrocket if implemented without insurance coverage for such an option, alongside a
repeal of the contraceptive mandate. 225 Similarly, experts who have supported OTC access
to OC for decades have come out against these Republicans' stated plan. They say that it
is not feasible and is simply an individual liberty mask for making access more difficult.226
Democrats are resisting the option for their own reasons. The ACA and its contraceptive
mandate were politically costly, and they do not want to see that effort dismantled.227
Also frustrating is the realization that these candidates are making mere campaign
promises, as Congress would not be in charge of a switch to OTC access, as this decision
under the FDA's purview. 228 Elected representatives and senators would have little to no
control over such a policy change. Additionally, the switch is unlikely to happen anytime
soon; no drug company has made an application to sell their oral contraceptive pill OTC
yet, according to FDA records.229 Until that happens, an OTC option will not be seriously
223 Altman, supra note 221.
224 Protecting Access to Reproductive Health Care and Abortion as an Electoral Priority, GREENBERG
QUINLAN ROSNER RESEARCH (2014), http://plannedparenthoodaction.org/files/7714/1580/3490/11-11-14-
NARAL-PPAF-Post-Election-Poll-Memo.pdf [http://perna.cc/E995-59G2].
225 The Truth About Over-the-Counter Access to Birth Control, PLANNED PARENTHOOD, http://www.
plannedparenthoodaction.org/elections-politics/newsroom/press-releases/truth-about-over-counter-access-
birth-control [http://perna.cc/73UU-HJRF] (last accessed Jan. 25, 2015). Not to mention that many Republican
candidates support defunding Planned Parenthood altogether. See, e.g., Romney Reiterates Defunding Planned
Parenthood, POLITICO (Oct. 10, 2012, 15:50 EST), http://www.politico.com/blogs/bums-habernan/2012/10/
romney-reiterates-defunding-planned-parenthood- 138063.html [http ://penna.cc/6UFX-E8FP].
226 Thompson-Deveaux, supra note 199.
227 Cf Health Care, DEMOCRATS.ORG, http://www.democrats.org/issues/health-care [http://perma.cc/M5R8-
3HA4] (last accessed Apr. 2, 2015).
228 Burton & Andrews, supra note 221.
229 Burton & Andrews, supra note 221.
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considered. As exemplified with emergency contraception's switch to OTC status, FDA
approval might pose problems with administrative politics. The FDA also might balk
at allowing OTC OC access for women under eighteen for political reasons, although
the option is safe and would be helpful, if the emergency contraception example is any
indication.23°
To combat these issues, the public would need to be engaged and supportive of OTC
OC, and the FDA would need to learn from the critiques of its treatment of emergency
contraception. 23 1 Despite its relative futility, a few senators tried to introduce a bill that
would encourage the FDA to look into OTC OC. The bill did not pass. 232 It is also important
to note that sometimes citizen petitions from organizations other than drug companies
can lead to legalized OTC access. This is rare, but possible. This is what happened for
allergy medicine; Blue Cross Blue Shield of California submitted a petition, instead of a
drug company, and the FDA responded. 233 That the insurer obviously had the incentive to
apply for the change indicates that, while an OTC system switch would have saved society
money, drug companies were likely benefitting by keeping a prescription access system. If
drug companies are similarly resistant to an OTC switch, as are insurers, 234 perhaps another
group, like health care providers, could write the petition instead, as technically any citizen
may submit a petition for a rulemaking. 235
These factors leave the debate regarding OTC access to oral contraceptives with only
suboptimal policy options on the table. The status quo is inadequate because the ACA's
structure disproportionately favors women with more resources and insurance, and
it leaves out large numbers of women. The Republican idea, similarly, would result in
230 See supra notes 130-131 and accompanying text.
231 See Lisa Heinzerling, Note, The FDA Plan B Fiasco: Lessons for Administrative Law, 102 Geo. L.J.
927, 981 (2014).
232 Preserving Religious Freedom and a Woman's Access to Contraception Act, S. 2605, 113th Cong. § 3
(2014).
233 Sullivan et al., supra note 188, at 1383.
234 This is what one would expect if their current low costs of birth control are due to their bargaining power
with drug manufacturers. See supra notes 181-189 and accompanying text.
235 Comment on Proposed Regulations and Submit Petitions, FDA.Gov, http://www.fda.gov/
Regulatorylnformation/Dockets/Comments/default.htm?utmsource=rs s&utmmedium=rs s&utm_
campaign=comment-on-proposed-regulations-and-submit-petitions [http://penna.cc/649G-W5P7] (last visited
Mar. 4, 2015).
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lessened access to OC, particularly if they are able to work towards a repeal of the ACA's
contraceptive mandate. Under this plan, OC would be available only with a prescription
and with a high out-of-pocket cost for all individuals. This is where a hybrid solution,
with a reimbursement requirement, could work to satisfy the concerns of both sides. The
possibility of working to perfect such a middle solution is becoming increasingly plausible,
given the shift in public discourse about OC in the past few months.
C. Cultural Issues
An easy response to the question of why access to OC is such a political quagmire is
that the United States has regulated women's access to OC since its introduction and that,
culturally, the United States is not ready to allow women to have full access to contraception
without regulation. In attempting to achieve reproductive autonomy, it is concerning that
access to OC is continually framed as a female issue. While alternatives like male birth
control have been proposed and are in development, society as a whole continues to see
contraception, whether OC or another form, as a women's issue because women are the
ones who get pregnant. Men, for obvious reasons, are not at risk for the same potential
consequence. 2 6 In the 1970s, after Griswold v. Connecticut,23 7 it seemed like the United
States would fully liberalize access to contraception-removing government regulation
from the matter entirely.238 This was not what happened. Instead, the frame of the debate
shifted entirely. Conservatives reframed the issue as a moral problem, and the argument
surrounding contraception moved away from focusing on reproductive freedom. 239
Still, the truth of the OC story is more complicated than this cultural argument portrays
it. Access to contraceptives, as well as abortion, have had incredibly varied support over
the past century. They have intermittently been intensely controversial, as well as not.24°
Plus, the controversies that have existed remained even when more of the public skewed
236 LuizaAK Hoga et al., AdultMen :' Beliefs, Values, Attitudes and Experiences Regarding Contraceptives:
a Systematic Review of Qualitative Studies, 23 J. CLINICAL NURSING 927, 930 (2014).
237 Griswold v. Connecticut, 381 U.S. 479, 479 (1965).
238 Rebecca Leber, It Astounding that We're Still Debating the Pill after 50 Years, NEW REPUBLIC (Oct.
12, 2014), http://www.newrepublic.com/article/119776/j onathan-eig-birth-control-and-reproductive-rights
[http ://penna.cc/6ZCK-LL7E].
239 Id.
240 The 1910s, 1930s, and 1960s all saw great advancements for contraception, with little pushback. GENE
BURNS, THE MORAL VETO 11 (2005).
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towards consensus. Issue framing arguably explains this quirky history.2 1 Limiting frames
refer to how politicians and political groups shape their message on certain topics, so that
they are not directly negating what their opponents are saying. Instead, they conceive of the
problem differently and insist that the other side is missing the point.242 Debates that frame
issues like this often also bring intense moral views along with them. Counter-intuitively,
issues that create significant controversy, particularly moral controversy, achieve fewergoals than issues that gamner less atention. 243 This is true even if the most vocal opposition
is only a small minority. By using a kind of "moral veto" this opposition can effectively
block policy change, and this has effectively happened for the issue of access to OC.244
These observations are both good and bad news for OTC OC. Encouragingly, given the
wide array of potential benefits OC offers and the ways in which it can benefit individual
women differently, OTC OC could muster an array of interests to champion its cause. A
diverse coalition would hopefully yield more successful results, once a diverse coalition is
involved. Nonetheless, the marked increase in Americans' acceptance of sexual liberty and
reproductive autonomy 245 might not help while the issue is still so polarized. Even if the
majority of the United States supports OTC OC, 24 6 a small minority might exercise their
moral veto.
The potential of using such a moral veto makes it particularly interesting that
Republicans have started supporting OTC OC at all. A diverse coalition would hopefully
yield more successful results. In essence, the candidates that have voiced their support for
241 Id. at 6.
242 Obvious examples of this are the pro-choice and pro-life frames for arguing about the availability of
abortion. Id. at 7-10.
243 Id. at 11 (stating that movements that have a plurality of differing, but combined, interests in support of
its goal-even if for varying reasons-generally achieve their objectives more successfully).
244 Id. at 23 ("Groups that exercise moral vetoes do so because they tap into general cultural predispositions
that may be somewhat inchoate but that nevertheless exist. For example, the potential to link contraception to
unpopular images of sexual promiscuity was ... central to the veto that the Roman Catholic hierarchy exercised
on numerous legislatures.").
245 See, e.g., Arland Thornton & Linda Young-DeMarco, Four Decades of Trends in Attitudes Toward
Family Issues in the United States: The 1960s through the 1990s, 63 J. MARRIAGE & FAN. 1009, 1009 (2001)
(finding that, among Americans in the 1990s as opposed to the 1960s, more people supported cohabitation
before marriage, unmarried childbearing, premarital sex, and first marriage at a later age).
246 Including people who are religious. Laura F. Romo et al., Sociocultural and religious influences on the
normative contraceptive practices ofLatino women in the United States, 69 CONTRACEPTION 219, 219 (2004).
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OTC access have relinquished their moral veto of contraception. Consequently, the frame
abruptly shifted from contraception as a moral issue regarding promiscuity to regulated
access to OC as a personal liberty issue-as in, OC changed from a bad to be avoided to a
good to be liberalized. Liberals have responded that OTC access leaves out women on the
margins and have opposed its implementation.247
It is true that the Republican proposal ignores several pressing concerns, but without
the moral dimension, the disagreement then stems, not from whether OC itself is good or
bad, but from how much support the government gives, or requires insurance companies
to give, to women who would not be able to purchase OC on their own. Such a dispute
does not carry the same intense polarization. Many policy issues in America split over
this same divide-taxation and unemployment benefits being a few of them. This new
frame also gives a wider margin of mutually agreeable solutions, which makes OTC OC
more likely to be a success.248 Whether or not a policy change is for the best, the reality
is that, in the United States, although scientific data and empirical conclusions are often
brandished in health care debates, values and ideologies have as much to do with shaping
policy outcomes, as do the numbers.249
CONCLUSION
OTC access for OC should be implemented in the United States. An OTC system
would address existing issues within the ACA regarding reproductive access and provide
OC's benefits to women who could gain the most from them. Women want an OTC option,
and it would be safe. OTC OC is a success in other countries. OTC access would save
societal costs on health care, and it would reduce women's individual nonmonetary costs of
using OC. Perhaps most importantly, OTC OC would increase women's control over their
contraceptive decisions-just knowing that OC would be available in a pharmacy, without
numerous procedural difficulties to first maneuver through, would empower women to
obtain the OC they clearly want.
247 Drum, supra note 216.
248 BURNS, supra note 240, at 11.
249 PATEL & RUSHEFSKY, supra note 58, at 3:
Debates over health policy are played out through the rhetorical use of language and the
strategic portrayal of social situations. Policy making revolves around the naming and
framing of a problem, the specification of problem boundaries, and the definition and
negotiation of the ideas and values that guide the ways citizens create a shared meaning
that motivates them to act.
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The most compelling counterargument is that OTC OC would cost more than women
on the margins are able to pay for it, and that racial effects, income effects, and other
structural disadvantages would prevent these women from benefitting as much from OTC
OC, even if they could access it. But, in response to this valid cost concern, a simple
administrative policy change would potentially help: by requiring Medicaid and private
insurers to reimburse women for OTC purchases, the powerful players in the health care
system would then be invested in driving down the cost for OTC OC. This would ensure that
the demand for OTC OC rose to meet increased supply and those prices became reasonable
and competitive. With the recent shift in the political framing of the contraceptive issue, it
is possible that this is a practically feasible proposition.
As for how this would help women who are not prevented under the ACA from realizing
the full benefits of OC, OTC access would not be able to correct these disparities entirely.
There is, though, the likely possibility that increased access to OC outside of doctors'
offices would be more beneficial to these women than a prescription-only system, and the
spillover benefits of being more able to plan pregnancies would expand to women on the
margins. This possibility makes OTC OC worthwhile.
Too often in the United States, decisions about women's reproductive health have not
been based on public health data, economic theory, or women's own opinions. OTC OC
is a policy change backed by all three of these considerations. Public support for OTC OC
is important to put the pressures necessary for implementation on drug manufacturers,
insurers, and the FDA. As such, understanding fully why OTC access would be beneficial,
what policy would make it workable, and what its potential tradeoffs could be is critical.
Even if not a panacea for all the issues that women currently face with regard to autonomy
in reproductive decisions, this is a chance to open up access in a meaningful and beneficial
way-to put reproductive autonomy on local pharmacy shelves.
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